http://topics.nytimes.com/top/news/business/companies/iaso-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/horizon-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/aspenbio-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/china-pharma-holdings-inc/index.html
http://topics.nytimes.com/top/news/business/companies/kite-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/cardiome-pharma-corporation/index.html
http://topics.nytimes.com/top/news/business/companies/scolr-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/nutra-pharma-corporation/index.html
http://topics.nytimes.com/top/news/business/companies/recro-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/targeted-medical-pharma-inc/index.html
http://dealbook.nytimes.com/2014/11/06/drug-maker-perrigo-to-acquire-omega-pharma/
http://topics.nytimes.com/top/news/business/companies/novadel-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/bio-blast-pharma-ltd/index.html
http://topics.nytimes.com/top/news/business/companies/zosano-pharma-corporation/index.html
http://www.nytimes.com/2014/11/11/opinion/big-pharma-and-ebola.html
http://www.nytimes.com/aponline/2014/11/06/business/ap-us-perrigo-omega-acquisition.html
http://www.nytimes.com/reuters/2014/10/20/business/20reuters-omega-actavis.html
http://www.nytimes.com/reuters/2014/10/29/technology/29reuters-google-pharmaceuticals-settlement.html
http://www.nytimes.com/reuters/2014/10/24/business/24reuters-hikma-pharma-warning-fda.html
http://www.nytimes.com/aponline/2014/10/03/business/ap-us-salix-inversion-scuttled.html
http://www.nytimes.com/aponline/2014/09/22/business/ap-us-auxilium-pharmaceuticals-endo-international.html
http://www.nytimes.com/reuters/2014/10/09/business/09reuters-auxilium-pharm-offer-endo-intl.html
http://www.nytimes.com/reuters/2014/10/15/business/15reuters-markets-stocks-europe.html
http://www.nytimes.com/aponline/2014/09/16/business/ap-us-endo-auxilium.html
http://www.nytimes.com/reuters/2014/09/21/sports/cycling/21reuters-cycling-world-ttt.html
http://query.nytimes.com/gst/fullpage.html?res=9B01E0D71731F937A35755C0A9609C8B63
http://www.nytimes.com/reuters/2014/09/18/business/18reuters-sinclair-results.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320129.html
http://www.nytimes.com/reuters/2014/09/23/business/23reuters-markets-stocks-ftse.html
http://www.nytimes.com/2001/02/08/us/national-news-briefs-raids-in-kentucky-aim-at-deadly-new-drug.html
http://www.nytimes.com/2001/02/08/us/national-news-briefs-raids-in-kentucky-aim-at-deadly-new-drug.html
http://www.nytimes.com/2007/07/21/business/21pharma.html
http://www.nytimes.com/2009/01/24/business/24pharma.html
http://www.nytimes.com/2005/08/27/business/27drug.html
http://www.nytimes.com/2001/08/07/nyregion/metro-briefing-connecticut-hartford-warning-on-painkiller.html
http://www.nytimes.com/2007/05/10/business/11drug-web.html
http://www.nytimes.com/2004/04/14/business/company-news-purdue-pharma-to-cut-nearly-300-jobs-in-connecticut.html
http://www.nytimes.com/2001/11/09/us/national-briefing-south-florida-inquiry-on-painkiller.html
http://www.nytimes.com/reuters/2014/09/16/business/16reuters-auxilium-pharm-offer-endo-intl.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176796.html
http://www.nytimes.com/2004/11/06/business/06drug.html
http://www.nytimes.com/2002/03/30/nyregion/c-corrections-311758.html
http://www.nytimes.com/reuters/2014/10/01/business/01reuters-flu-vaccine-analysis.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176788.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176800.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176770.html
http://www.nytimes.com/2010/12/16/business/16purdue.html
http://www.nytimes.com/2004/05/08/nyregion/city-claims-drug-maker-overcharged-for-painkiller.html
http://www.nytimes.com/2003/08/12/business/generics-shake-up-a-drug-industry.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320137.htmlhttp://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320137.html
http://www.nytimes.com/2001/02/14/opinion/l-pain-relief-for-cancer-898465.html
http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html
http://www.nytimes.com/2001/08/09/us/national-briefing-science-and-health-new-form-for-abused-painkiller.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320110.html
http://www.nytimes.com/1994/11/22/business/biochem-pharma.html
http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html
http://www.nytimes.com/2003/09/04/business/media-business-advertising-maker-oxycontin-painkiller-that-addictive-sponsors.html
http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html
http://www.nytimes.com/2011/06/16/health/16oxy.html/data/daily/2007/10/05/526452.sgml
http://www.nytimes.com/2007/07/20/business/20oxy.html
http://www.nytimes.com/2005/06/08/business/08drug.html
http://www.nytimes.com/2004/04/18/nyregion/worth-noting-ruling-forces-company-to-cut-jobs-in-stamford.html
http://www.nytimes.com/2001/08/13/us/maker-chose-not-to-use-a-drug-abuse-safeguard.html
http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html
http://www.nytimes.com/2011/06/16/health/16oxy.html
http://www.nytimes.com/2007/05/09/business/09purdue.html
http://www.nytimes.com/2001/08/18/opinion/l-abuse-of-oxycontin-756300.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176761.htmlhttp://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176753.html
http://topics.nytimes.com/top/news/business/companies/blackstone-lake-minerals-inc/index.html
http://topics.nytimes.com/top/news/business/companies/marshall-edwards-inc/index.html
http://topics.nytimes.com/top/news/business/companies/nexgen-biofuels-ltd/index.html
http://www.nytimes.com/2014/03/13/business/abuse-resistant-hydrocodone-could-sink-sales-of-new-drug.html
http://www.nytimes.com/2003/10/28/business/world-business-briefing-europe-germany-drug-maker-cuts-outlook.html
http://query.nytimes.com/gst/abstract.html?res=9806E5DA123CE23BBC4C52DFB7668382659EDE
http://www.nytimes.com/2007/06/19/business/19drug.html
http://www.nytimes.com/2004/01/06/business/judge-says-maker-of-oxycontin-misled-officials-to-win-patents.html
http://www.nytimes.com/2007/12/28/us/politics/28oxycontin.htmlhttp://www.nytimes.com/2000/01/20/business/world-business-briefing-europe-basf-pharma-reorganizes.html
http://www.nytimes.com/1996/08/20/business/profits-rise-12.8-at-schwarz-pharma.html
http://www.nytimes.com/1992/02/11/business/market-place-a-drug-flunks-a-stock-collapses.html
http://www.nytimes.com/2007/05/11/business/11drug.html
/data/daily/2004/09/30/138428.sgml
http://query.nytimes.com/gst/abstract.html?res=9400E7DF1238E23BBC4951DFBF66838F649EDE
http://query.nytimes.com/gst/fullpage.html?res=9C01EEDB1F31F935A1575AC0A9609C8B63
http://www.nytimes.com/2005/07/14/health/14asthma.html
http://query.nytimes.com/gst/fullpage.html?res=9505E7DB1531F93BA35755C0A9609C8B63
http://www.nytimes.com/2002/11/06/business/company-news-astrazeneca-to-appeal-us-court-ruling-on-generics.htmlhttp://www.nytimes.com/1999/11/26/business/basf-says-it-may-sell-or-exchange-its-pharmaceuticals-unit.html
http://www.nytimes.com/1992/02/11/nyregion/mother-gets-prison-term-in-fatal-beating-of-boy.html
http://www.nytimes.com/2003/11/05/business/company-said-to-develop-substitute-for-painkiller.html
http://www.nytimes.com/2002/05/30/nyregion/metro-briefing-connecticut-stamford-big-client-for-giuliani-s-company.html
http://www.nytimes.com/1999/06/19/business/company-news-alpharma-adds-german-generic-drug-business.html
http://www.nytimes.com/2008/09/01/business/worldbusiness/02drug.html
http://www.nytimes.com/2000/06/24/business/international-business-aventis-unit-sets-big-investment-biotechnology-start-up.html
http://query.nytimes.com/gst/fullpage.html?res=9B0DE6D7173FF936A15750C0A9639C8B63
http://www.nytimes.com/1992/04/05/business/after-granola-what-lichtwer-s-little-garlic-pills.html
http://www.nytimes.com/1989/02/19/realestate/postings-canadians-in-connecticut-armed-to-fit.htmlhttp://www.nytimes.com/2001/12/12/us/official-faults-drug-company-for-marketing-of-its-painkiller.html
http://www.nytimes.com/2013/04/17/business/fda-bars-generic-oxycontin.html
http://www.nytimes.com/2002/12/12/business/technology-briefing-e-commerce-biovail-buys-2-companies-for-190-million.html
http://dealbook.nytimes.com/2013/05/20/royalty-pharma-raises-bid-for-a-resistant-elan/
http://www.nytimes.com/2002/11/12/business/company-news-drug-tester-rejects-chairman-s-takeover-bid.html
http://www.nytimes.com/2001/06/12/us/national-briefing-mid-atlantic-west-virginia-state-sues-drug-maker.html
http://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.html
http://query.nytimes.com/gst/fullpage.html?res=9B0DE6D7173FF936A15750C0A9639C8B63
http://www.nytimes.com/1992/04/05/business/after-granola-what-lichtwer-s-little-garlic-pills.html
http://www.nytimes.com/1989/02/19/realestate/postings-canadians-in-connecticut-armed-to-fit.htmlhttp://www.nytimes.com/2004/01/07/business/connecticut-to-investigate-oxycontin-maker.html
http://www.nytimes.com/2004/01/13/business/oxycontin-manufacturer-seeks-delay-of-rival-drugs.html
http://www.nytimes.com/1999/07/16/business/company-news-canadian-drug-maker-offers-to-buy-scandipharm.html
http://www.nytimes.com/2002/04/25/business/company-news-vertex-says-arthritis-drug-falls-short-of-expectations.html
http://dealbook.nytimes.com/2010/06/03/astellas-extends-tender-offer-for-osi/
http://dealbook.nytimes.com/2013/06/17/battle-for-elan-in-doubt-after-shareholders-approve-buyback-plan/
http://www.nytimes.com/2013/04/20/opinion/the-loss-of-generic-oxycontin.html
http://www.nytimes.com/2002/10/15/business/company-news-head-of-drug-research-company-asks-to-buy-it.html
http://www.nytimes.com/2000/07/14/business/company-news-king-pharmaceuticals-agrees-to-buy-a-rival.html
http://www.nytimes.com/video/multimedia/100000002838976/big-pharma-braces-for-ma-wave.htmlhttp://query.nytimes.com/gst/abstract.html?res=9902E2DF1630EE3ABC4851DFB366838B699FDE
http://query.nytimes.com/gst/fullpage.html?res=9C03E3D81631F934A25754C0A9619C8B63
http://www.nytimes.com/aponline/2014/02/11/business/ap-us-mallinckrodt-acquisition.html
http://www.nytimes.com/2001/07/26/us/effort-to-cut-a-painkiller-s-use.html
http://www.nytimes.com/2014/07/24/business/fda-approves-pain-drug-meant-to-discourage-abuse.html
http://www.nytimes.com/2002/10/14/business/market-place-astrazeneca-has-won-battle-but-its-war-with-generic-drug-makers.html
http://www.nytimes.com/2001/10/28/us/overdoses-of-painkiller-are-linked-to-282-deaths.html
http://www.nytimes.com/2001/03/05/business/sales-of-painkiller-grew-rapidly-but-success-brought-a-high-cost.html
http://www.nytimes.com/1999/04/18/realestate/in-the-region-connecticut-drug-maker-buys-vacant-gte-building-in-stamford.html
http://www.nytimes.com/1984/01/14/business/monsanto-add-belgian-concern-st-louis-jan-13-ap-monsanto-company-announced-it.htmlhttp://www.nytimes.com/2006/11/24/business/24cancer.html
http://query.nytimes.com/gst/fullpage.html?res=9407E4D81E30F936A15751C1A9629C8B63
http://dealbook.nytimes.com/2010/05/16/osi-to-sell-itself-to-astellas-for-4-billion/
http://www.nytimes.com/1993/09/17/business/company-news-sandoz-in-pact-to-make-drugs-for-immune-system.html
http://www.nytimes.com/2007/12/11/business/worldbusiness/11drug.html
http://query.nytimes.com/gst/abstract.html?res=9504E5DE163FE731A25754C1A96F9C94619FD7CF
http://dealbook.nytimes.com/2013/06/14/elan-puts-itself-up-for-sale/
http://dealbook.nytimes.com/2013/06/06/elan-finds-creative-poison-pill-to-defend-against-a-hostile-bid/
http://www.nytimes.com/2010/05/17/business/global/17osi.html
http://www.nytimes.com/2003/05/28/business/company-news-drug-company-board-says-takeover-offer-is-too-low.htmlhttp://dealbook.nytimes.com/2013/02/25/buyout-offer-will-likely-not-end-elans-merger-ambitions/
http://www.nytimes.com/2013/01/16/nyregion/ny-police-to-track-drugstore-robbers-via-decoy-bottles.html
http://www.nytimes.com/2003/12/21/weekinreview/the-public-editor-you-can-stand-on-principle-and-still-stub-a-toe.html
http://www.nytimes.com/2001/01/03/business/world-business-briefing-americas-heart-drug-rights-acquired.html
http://dealbook.nytimes.com/2009/10/13/onyx-pharma-swallows-proteolix/
http://dealbook.nytimes.com/2007/01/02/british-healthcare-firm-sinclair-pharma-plans-ipo/
http://www.nytimes.com/1995/06/06/business/block-to-sell-parts-of-unit.html
http://dealbook.nytimes.com/2013/06/07/royalty-pharma-raises-its-bid-for-elan-again/
http://www.nytimes.com/2001/05/01/us/us-asks-painkiller-maker-to-help-curb-wide-abuse.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320153.htmlhttp://www.nytimes.com/2004/08/27/business/company-news-merck-of-germany-to-buy-pfizer-generic-drug-unit.html
http://www.nytimes.com/1992/10/07/business/continental-pharma-reports-earnings-for-year-to-july-31.html
http://www.nytimes.com/2012/09/01/business/fda-approves-prostate-cancer-drug.html
http://www.nytimes.com/1994/11/24/business/company-news-biochem-drops-sale-of-north-american-vaccine-shares.html
http://www.nytimes.com/2014/01/29/health/drug-shows-promise-in-advanced-prostate-cancer-when-used-before-chemotherapy.html
http://www.nytimes.com/2003/07/26/business/company-news-mgi-pharma-wins-fda-approval-for-antinausea-drug.html
http://www.nytimes.com/reuters/2014/05/26/business/26reuters-china-pharmaceuticals-margins.html
http://www.nytimes.com/1992/10/01/business/biochem-pharma-reports-earnings-for-qtr-to-july-31.html
http://www.nytimes.com/aponline/2013/02/25/business/ap-us-royalty-pharma-elan.html
http://www.nytimes.com/aponline/2013/02/01/business/ap-us-kalobios-pharma-ipo.htmlhttp://www.nytimes.com/aponline/2012/12/31/us/ap-us-hgh-growing-use.html
http://www.nytimes.com/reuters/2014/04/30/business/30reuters-drug-britain-scientists.html
http://www.nytimes.com/2001/07/29/weekinreview/ideas-trends-big-pharma-ogles-yasgur-s-farm.html
http://www.nytimes.com/1993/10/05/business/continental-pharma-reports-earnings-for-year-to-july-31.html
http://www.nytimes.com/2003/12/21/nyregion/li-work.html
http://www.nytimes.com/aponline/2013/05/28/business/ap-us-astrazeneca-acquisition.html
http://dealbook.nytimes.com/2010/10/11/chinese-pharma-set-to-raise-741-million/
http://dealbook.nytimes.com/2009/12/08/apax-buys-pharma-support-firm-marken/
http://dealbook.nytimes.com/2009/05/18/takeda-swallos-idm-pharma-for-around-70-million/
http://www.nytimes.com/1993/04/13/business/company-news-merck-plans-to-expand-its-generic-drug-division.htmlhttp://www.nytimes.com/1992/08/06/business/company-news-american-home-products-buying-german-drug-concern.html
http://www.nytimes.com/aponline/2014/06/20/business/ap-us-ipo-roundup-pricing.html
http://www.nytimes.com/reuters/2014/05/12/business/12reuters-lumena-shire.html
http://www.nytimes.com/1992/04/03/business/biochem-pharma-reports-earnings-for-year-to-jan-31.html
http://www.nytimes.com/reuters/2014/05/24/business/24reuters-china-pharmaceuticals-margins.html
http://www.nytimes.com/aponline/2012/08/06/us/ap-us-teva-pharma-sec-investigation.html
http://www.nytimes.com/1992/06/22/business/continental-pharma-reports-earnings-for-qtr-to-april-30.html
http://dealbook.nytimes.com/2013/06/18/royalty-pharma-drops-bid-for-elan/
http://www.nytimes.com/aponline/2014/04/25/business/ap-us-prestige-brands-acquisition.html
http://www.nytimes.com/aponline/2012/12/21/us/ap-us-hgh-growing-use.htmlhttp://www.nytimes.com/reuters/2012/09/16/business/16reuters-allianceboots-china-stake.html
http://www.nytimes.com/reuters/2012/09/11/business/11reuters-india-fdi.html
http://www.nytimes.com/1995/12/22/business/international-briefs-smithkline-acquisition.html
http://www.nytimes.com/2009/12/13/business/13drug.html
http://www.nytimes.com/aponline/2013/06/07/business/ap-us-elan-royalty-pharma-summary-box.html
http://dealbook.nytimes.com/2013/02/25/royalty-pharma-proposes-to-buy-elan-for-6-6-billion/
http://dealbook.nytimes.com/2009/08/21/adamas-completes-40-million-round/
http://www.nytimes.com/aponline/2014/05/13/business/ap-us-allergan-valeant.html
http://www.nytimes.com/1993/12/24/business/continental-pharma-reports-earnings-for-qtr-to-oct-31.html
http://www.nytimes.com/reuters/2012/11/12/world/europe/12reuters-croatia-pharmaceuticals-bribery.htmlhttp://www.nytimes.com/1986/03/16/us/tainted-anticoagulant-drug-for-treating-cancer-recalled.html
http://www.nytimes.com/reuters/2013/03/06/business/06reuters-royaltypharma-elan.html
http://www.nytimes.com/1991/05/23/business/johnson-merck-to-buy-german-drug-unit.html
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-novartis.html
http://www.nytimes.com/reuters/2013/02/11/business/11reuters-perrigo-acquisition.html
http://www.nytimes.com/aponline/2012/10/15/us/ap-us-wall-street-close.html
http://www.nytimes.com/2012/09/01/business/fda-approves-prostate-cancer-drug.html
http://www.nytimes.com/2000/12/12/business/technology-shire-offers-4-billion-for-biochem.html
http://www.nytimes.com/1992/09/05/business/merck-establishes-division-to-produce-a-generic-drug.html
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-teva-pharma-sec-investigation-summary-box.htmlhttp://www.nytimes.com/2008/09/02/business/worldbusiness/02fashion.html
http://www.nytimes.com/2004/02/24/business/company-news-merck-plans-to-buy-developer-of-cancer-drug.html
http://www.nytimes.com/2000/10/05/business/drug-company-buys-distributor.html
http://www.nytimes.com/1986/07/08/business/bausch-lomb-plans-acquisition.html
http://www.nytimes.com/2013/11/15/business/chicago-reviews-marketing-by-makers-of-narcotic-painkillers.html
http://www.nytimes.com/2001/07/21/business/world-business-briefing-europe-britain-skin-care-deal.html
http://www.nytimes.com/1992/09/08/business/merck-sets-generic-drug-sales.html
http://www.nytimes.com/2007/05/08/nyregion/08mbrfs-drug.html
http://www.nytimes.com/2003/04/12/business/company-news-chairman-is-buying-quintiles-transnational.html
http://www.nytimes.com/reuters/2012/08/20/business/20reuters-novartis-india.htmlhttp://www.nytimes.com/2014/08/25/us/chicago-and-2-california-counties-sue-drug-companies-over-painkiller-marketing.html
http://www.nytimes.com/aponline/2013/06/07/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/aponline/2013/04/15/business/ap-us-royalty-pharma-elan-offer.html
http://dealbook.nytimes.com/2012/04/11/takeda-of-japan-buys-url-pharma-for-800-million/
http://dealbook.nytimes.com/2008/02/07/3i-takes-another-shot-a-pharma-with-api-deal/
http://www.nytimes.com/reuters/2014/05/06/business/06reuters-healthcare-m-a-factbox.html
http://www.nytimes.com/reuters/2012/08/19/business/19reuters-novartis-india.html
http://www.nytimes.com/1992/04/03/business/continental-pharma-reports-earnings-for-qtr-to-jan-31.html
http://www.nytimes.com/reuters/2013/06/07/business/07reuters-royalty-elan.html
http://dealbook.nytimes.com/2007/11/29/tpg-to-acquire-axcan-pharma-for-13-billion/http://dealbook.nytimes.com/2007/10/16/canadas-akela-pharma-eyes-us-ipo/
http://www.nytimes.com/reuters/2013/06/10/business/10reuters-dealtalk-drugmakers-ireland.html
http://www.nytimes.com/aponline/2013/04/22/business/ap-eu-ireland-elan.html
http://www.nytimes.com/aponline/2013/03/21/business/ap-us-enanta-pharmaceuticals-ipo.html
http://www.nytimes.com/aponline/2013/09/19/business/ap-us-acceleron-pharma-ipo-mover.html
http://www.nytimes.com/aponline/2013/07/18/business/ap-us-oncomed-pharma-ipo-pricing.html
http://www.nytimes.com/2000/09/27/business/company-news-novartis-pharma-and-biotransplant-in-alliance.html
http://www.nytimes.com/aponline/2013/06/19/world/europe/ap-eu-eu-generic-medicine.html
http://www.nytimes.com/reuters/2013/03/04/business/04reuters-elan-royalty.html
http://dealbook.nytimes.com/2007/11/19/zosano-pharma-swallows-90-million/http://www.nytimes.com/reuters/2013/08/01/sports/cycling/01reuters-cycling-omegapharma-uran.html
http://www.nytimes.com/reuters/2013/07/23/us/23reuters-gsk-china.html
http://www.nytimes.com/reuters/2013/07/13/sports/cycling/13reuters-cycling-tour.html
http://www.nytimes.com/reuters/2013/04/11/business/11reuters-royaltypharma-elan.html
/data/daily/2004/09/02/845396.sgml
http://www.nytimes.com/2001/03/22/business/the-media-business-advertising-addenda-purdue-pharma-has-new-agency.html
http://www.nytimes.com/2013/01/02/health/drug-makers-losing-a-bid-to-foil-generic-painkillers.html
http://www.nytimes.com/1993/12/17/business/company-news-ciba-geigy-in-china.html
http://www.nytimes.com/aponline/2013/06/18/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/reuters/2013/03/27/business/27reuters-india-drugs-glivec.htmlhttp://dealbook.nytimes.com/2010/02/16/quintiles-expands-stake-in-big-pharma/
http://www.nytimes.com/1995/05/10/business/al-pharma-alon-reports-earnings-for-qtr-to-mar-31.html
http://www.nytimes.com/2005/06/24/health/24drugs.html
http://query.nytimes.com/gst/fullpage.html?res=9801E7DD1231F931A25757C0A9649D8B63
http://www.nytimes.com/reuters/2014/06/01/business/01reuters-shire-m-a-nps.html
http://www.nytimes.com/reuters/2013/12/15/business/15reuters-markets-india-shares.html
http://www.nytimes.com/aponline/2013/06/27/business/ap-us-fda-online-pharmacies-summary-box.html
http://www.nytimes.com/aponline/2013/05/20/business/ap-us-elan-royalty-pharma-offer.html
http://dealbook.nytimes.com/2006/07/19/gilead-acquires-corus-pharma-for-365-million/
http://www.nytimes.com/reuters/2014/04/07/business/07reuters-daiichi-sankyo-ranbaxy-sunpharma-profit.htmlhttp://www.nytimes.com/reuters/2012/11/05/business/05reuters-abbott.html
http://www.nytimes.com/reuters/2013/08/02/business/02reuters-india-gsk.html
http://www.nytimes.com/reuters/2013/09/12/business/12reuters-india-drugs-analysis.html
http://www.nytimes.com/reuters/2014/01/17/world/17reuters-safrica-pharma.html
http://www.nytimes.com/1990/04/05/business/continental-pharma-cryosan-inc-reports-earnings-for-qtr-to-jan-31.html
http://query.nytimes.com/gst/abstract.html?res=9407E2D71638EF3BBC4851DFB7668382649EDE
http://www.nytimes.com/reuters/2013/02/26/business/26reuters-royaltypharma-endo.html
http://www.nytimes.com/1992/01/02/business/continental-pharma-cryosan-reports-earnings-for-qtr-to-oct-31.html
http://www.nytimes.com/1989/07/11/business/continental-pharma-cryosan-inc-reports-earnings-for-qtr-to-april-30.html
http://www.nytimes.com/reuters/2014/07/28/business/28reuters-reckitt-benc-grp-pharmaceuticals.htmlhttp://www.nytimes.com/aponline/2014/02/07/us/politics/ap-us-sports-doping-drugmakers.html
http://www.nytimes.com/reuters/2014/02/02/business/02reuters-novartis-jobs.html
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-k-v-pharma-bankruptcy.html
http://www.nytimes.com/1994/11/02/business/al-pharma-inc-alon-reports-earnings-for-qtr-to-sept-30.html
http://www.nytimes.com/reuters/2014/04/06/business/06reuters-daiichi-sankyo-ranbaxy-sunpharma.html
http://www.nytimes.com/reuters/2014/03/13/business/13reuters-sun-pharma-india-fda.html
http://www.nytimes.com/1995/08/03/business/al-pharma-alon-reports-earnings-for-2d-qtr-to-jun-30.html
http://www.nytimes.com/1992/06/29/business/biochem-pharma-inc-reports-earnings-for-qtr-to-april-30.html
http://www.nytimes.com/reuters/2014/06/12/business/12reuters-china-pharmaceuticals.html
http://www.nytimes.com/2003/09/11/business/drug-panel-rejects-pleas-to-curb-sales-of-a-widely-abused-painkiller.htmlhttp://www.nytimes.com/2010/06/20/books/review/Scarf-t.html
http://www.nytimes.com/reuters/2014/06/12/business/12reuters-china-pharmaceuticals.html
http://www.nytimes.com/2003/09/11/business/drug-panel-rejects-pleas-to-curb-sales-of-a-widely-abused-painkiller.html
http://www.nytimes.com/reuters/2013/09/05/business/05reuters-china-bribery-probe.html
http://www.nytimes.com/reuters/2013/06/09/business/09reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/04/02/business/02reuters-india-pharmaceuticals.html
http://www.nytimes.com/reuters/2014/07/12/business/12reuters-merck-deals.html
http://www.nytimes.com/reuters/2014/04/29/business/29reuters-sanofi-earnings.html
http://www.nytimes.com/reuters/2014/03/12/business/12reuters-bayer-outlook.html
http://www.nytimes.com/2013/02/05/science/a-look-at-bad-pharma-and-science-as-performance.htmlhttp://www.nytimes.com/reuters/2014/04/23/business/23reuters-novartis-gsk-assetswaps.html
http://www.nytimes.com/aponline/2014/04/10/business/ap-us-adamas-pharma-ipo.html
http://www.nytimes.com/reuters/2014/03/19/business/19reuters-horizonpharma-acquisition.html
http://dealbook.nytimes.com/2014/01/08/forest-labs-to-buy-specialty-drug-maker-for-2-9-billion/
http://www.nytimes.com/reuters/2013/12/19/business/19reuters-markets-britain-stocks.html
http://www.nytimes.com/reuters/2013/06/09/business/09reuters-elan-royalty.html
http://dealbook.nytimes.com/2010/09/10/shanghai-pharma-plans-1-2-billion-hong-kong-i-p-o/
http://www.nytimes.com/2003/09/04/business/company-news-canadian-company-buys-drug-rights-from-abbott-labs.html
http://www.nytimes.com/2002/04/15/us/oxycontin-deaths-may-top-early-count.html
http://www.nytimes.com/1995/11/21/business/new-drug-to-fight-aids-is-approved-by-fda.htmlhttp://www.nytimes.com/1995/11/21/business/new-drug-to-fight-aids-is-approved-by-fda.html
http://www.nytimes.com/reuters/2014/06/17/business/17reuters-gw-pharma.html
http://dealbook.nytimes.com/2007/12/10/japans-eisai-to-cough-up-39-billion-for-mgi-pharma/
http://www.nytimes.com/2004/01/23/business/us-report-faults-maker-of-oxycontin.html
http://www.nytimes.com/2002/10/12/business/ruling-backs-some-patents-on-a-leading-ulcer-drug.html
http://dealbook.nytimes.com/2009/12/10/ex-ropes-gray-lawyer-pleads-guilty-in-galleon-case/
http://www.nytimes.com/reuters/2014/08/06/business/06reuters-markets-britain-stocks.html
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-usa-healthcare-mergers.html
http://www.nytimes.com/2000/10/29/magazine/the-way-we-live-now-10-29-00-pro-pharma.html
http://www.nytimes.com/reuters/2014/05/22/business/22reuters-roche-hldg-china.htmlhttp://www.nytimes.com/reuters/2014/05/04/business/04reuters-pharmaceuticals-sales.html
http://www.nytimes.com/reuters/2014/02/12/business/12reuters-reckittbenckiser-results.html
http://www.nytimes.com/1995/03/29/business/al-pharma-alon-reports-earnings-for-qtr-to-dec-31.html
http://www.nytimes.com/reuters/2013/07/03/business/03reuters-alliancepharma-interview.html
http://www.nytimes.com/reuters/2013/06/14/business/14reuters-royaltpharma-response.html
http://www.nytimes.com/2001/12/10/us/at-painkiller-trouble-spot-signs-seen-as-alarming-didn-t-alarm-drug-s-maker.html
http://www.nytimes.com/1994/04/28/business/company-news-merck-to-add-to-generic-line-of-drugs.html
http://query.nytimes.com/gst/abstract.html?res=9400E5DE143BE53ABC4C51DFB467838C649EDE
http://query.nytimes.com/gst/abstract.html?res=9C06E5DB103EE23BBC4B51DFBF66838C649EDE
http://www.nytimes.com/reuters/2013/09/18/business/18reuters-china-pharma-sales-analysis.htmlhttp://www.nytimes.com/reuters/2013/05/31/business/31reuters-meda-sunpharma.html
http://www.nytimes.com/reuters/2013/06/12/business/12reuters-pfizer-patent.html
http://www.nytimes.com/video/business/100000001643644/business-day-live-july-3-2012.html
http://www.nytimes.com/reuters/2013/07/29/business/29reuters-valeant-jobs.html
http://www.nytimes.com/2003/12/24/business/commercial-real-estate-regional-market-westchester-new-life-science-complex-for.html
http://www.nytimes.com/2004/03/24/business/company-news-fda-approves-generic-versions-of-oxycontin.html
http://www.nytimes.com/reuters/2014/04/09/business/09reuters-ranbaxy-sunpharma.html
http://www.nytimes.com/reuters/2014/04/07/business/07reuters-daiichi-sankyo-ranbaxy-sunpharma.html
http://dealbook.nytimes.com/2010/03/05/putting-high-takeover-premiums-in-perspective/
http://www.nytimes.com/reuters/2014/05/05/business/05reuters-ranbaxy-lab-sun-pharma-silverstreet.htmlhttp://query.nytimes.com/gst/abstract.html?res=990DE1DB1E39E134BC4A51DFB2668383679EDE
http://www.nytimes.com/video/2012/07/03/business/100000001643644/business-day-live-july-3-2012.html
http://www.nytimes.com/2008/03/08/world/europe/08heparin.html
http://dealbook.nytimes.com/2010/01/27/kurland-pleads-guilty-in-galleon-insider-case/
http://dealbook.nytimes.com/2010/01/27/kurland-will-not-cooperate-in-galleon-case/
http://dealbook.nytimes.com/2011/05/18/ex-diamondback-manager-pleaded-guilty-to-insider-trading/
http://dealbook.nytimes.com/2010/06/09/caseys-general-stores-loves-iowa/
http://query.nytimes.com/gst/abstract.html?res=9C0DE1D81539E433A25750C1A9629C946196D6CF
http://www.nytimes.com/2006/12/28/business/28generic.html
http://www.nytimes.com/2010/03/05/business/05views.htmlhttp://www.nytimes.com/reuters/2014/10/20/business/20reuters-sigma-tau-m-a-alfa.html
http://dealbook.nytimes.com/2010/03/22/the-price-of-goofs-in-deal-making/
http://www.nytimes.com/2005/04/20/theater/20place.html
http://www.nytimes.com/2014/11/15/world/asia/india-sterilization-deaths-linked-to-antibiotics-rat-poison.html
http://query.nytimes.com/gst/abstract.html?res=9E0DE3D8173BE430A75750C1A9679D946196D6CF
http://dealbook.nytimes.com/2010/03/05/another-deal-grab-bag-astellas-cf-airgas-and-more/
http://dealbook.nytimes.com/2012/07/03/business-day-live-glaxo-to-pay-3-billion-in-fines/
http://www.nytimes.com/aponline/2014/11/15/world/asia/ap-as-india-sterilization-deaths.html
http://dealbook.nytimes.com/2010/04/01/the-pace-of-deal-making-picks-up/
http://www.nytimes.com/reuters/2014/08/30/sports/cycling/30reuters-cycling-belgium-death.htmlhttp://www.nytimes.com/reuters/2014/10/22/business/22reuters-kremersurban-m-a-adventavista.html
http://dealbook.nytimes.com/2010/04/05/gazing-into-the-crystal-ball-for-april/
http://dealbook.nytimes.com/2014/11/17/pfizer-to-pay-up-to-2-9-billion-in-cancer-drug-deal-with-merck-of-germany/
http://www.nytimes.com/video/multimedia/100000002986933/asia-day-ahead-watch-out-for-the-ipo-effect.html
http://www.nytimes.com/video/multimedia/100000002858721/az-spurns-pfizer-bayermerck-deal-nears.html
http://www.nytimes.com/video/multimedia/100000002810736/cautionary-tale-for-japan-ma-in-ranbaxy-fail.html
http://www.nytimes.com/video/multimedia/100000003008328/abbvie-clinches-shire-deal.html
http://query.nytimes.com/gst/abstract.html?res=990DE4DA123DE333A25755C0A9619C946191D6CF
http://www.nytimes.com/reuters/2014/09/08/sports/cycling/08reuters-cycling-spain-fight.html
http://query.nytimes.com/gst/abstract.html?res=9503EFD9103DE03ABC4953DFBE668382659EDEhttp://www.nytimes.com/2002/02/26/us/national-briefing-rockies-montana-suit-against-drug-companies.html
http://www.nytimes.com/aponline/2014/11/14/world/asia/ap-as-india-sterilization-deaths.html
http://dealbook.nytimes.com/2007/02/02/hospira-seals-deal-for-mayne/
http://dealbook.nytimes.com/2010/05/24/behind-the-trends-in-an-m-a-uptick/
http://www.nytimes.com/aponline/2014/10/30/us/ap-us-nfl-drug-lawsuit.html
http://www.nytimes.com/2014/10/03/movies/the-culture-high-explores-marijuana-decriminalization.html
http://www.nytimes.com/reuters/2014/09/24/business/24reuters-markets-stocks-usa.html
http://www.nytimes.com/video/multimedia/100000002998939/shire-ready-to-recommend-higher-abbvie-bid.html
http://query.nytimes.com/gst/abstract.html?res=9F0CE7DA1338E53BBC4A53DFB767838C679EDE
http://www.nytimes.com/reuters/2014/09/22/business/22reuters-merck-sigma-aldrich.htmlhttp://www.nytimes.com/reuters/2014/11/03/business/03reuters-covance-m-a-laboratory-corp.html
http://www.nytimes.com/2012/10/17/sports/cycling/levi-leipheimer-dropped-from-cycling-team.html
http://query.nytimes.com/gst/abstract.html?res=9802E3DA1638E33BBC4950DFB3668388659EDE
http://query.nytimes.com/gst/abstract.html?res=9F01E3D91239E632A25756C0A9679C946794D6CF
http://query.nytimes.com/gst/abstract.html?res=9C0DE3D61F3CE73ABC4151DFB467838B659EDE
http://www.nytimes.com/2014/08/31/sports/cycling/valverde-keeps-lead-at-vuelta-a-espaa.html
http://query.nytimes.com/gst/abstract.html?res=9905E4D8113AE53BBC4B52DFB667838E649EDE
http://query.nytimes.com/gst/abstract.html?res=9A06E1DE133BE13ABC4A53DFB667838A679EDE
http://query.nytimes.com/gst/abstract.html?res=9A05E5DA173AE33BBC4F51DFB266838A659EDE
http://query.nytimes.com/gst/abstract.html?res=9F02E5DC1031E63ABC4C53DFB467838C649EDEhttp://query.nytimes.com/gst/abstract.html?res=9500EFDC163AE23BBC4053DFB5668389649EDE
http://www.nytimes.com/2005/07/19/business/19pharma.html
http://www.nytimes.com/reuters/2013/06/10/business/10reuters-elan-sharebuyback.html
http://www.nytimes.com/aponline/2014/10/15/us/politics/ap-us-supreme-court-generic-drug-dispute.html
http://www.nytimes.com/reuters/2014/10/15/us/politics/15reuters-usa-court-teva-arguments.html
http://www.nytimes.com/reuters/2014/10/01/world/asia/01reuters-aids-india.html
http://query.nytimes.com/gst/abstract.html?res=9E02E0DF1E30EE32A25752C1A9619C946694D6CF
http://www.nytimes.com/reuters/2014/09/02/sports/cycling/02reuters-cycling-spain.html
http://www.nytimes.com/reuters/2014/11/13/world/asia/13reuters-india-health-sterilisation.html
http://www.nytimes.com/aponline/2013/02/04/us/politics/ap-us-fda-cancer-drug.htmlhttp://www.nytimes.com/reuters/2014/08/22/sports/cycling/22reuters-cycling-britain-chavanel.html
http://www.nytimes.com/reuters/2014/10/07/world/africa/07reuters-health-ebola-pentagon.html
http://www.nytimes.com/reuters/2014/11/05/business/05reuters-health-ageing-drugmakers-analysis.html
http://www.nytimes.com/aponline/2014/10/26/us/ap-us-ebola-pharma-opportunity.html
http://query.nytimes.com/gst/abstract.html?res=9B00E1D8163BEF3ABC4950DFB7668388629EDE
http://www.nytimes.com/reuters/2014/10/03/us/politics/03reuters-usa-court-business-cases-factbox.html
http://query.nytimes.com/gst/abstract.html?res=9B07E4DD1030E43ABC4D53DFB366838B659EDE
http://www.nytimes.com/2000/09/29/business/company-news-king-pharmaceuticals-plans-to-stop-making-flu-vaccine.html
http://www.nytimes.com/reuters/2013/07/13/sports/cycling/13reuters-cycling-tour-winner.html
http://krugman.blogs.nytimes.com/2011/09/30/ireland-triumphs/http://www.nytimes.com/2000/09/29/business/company-news-king-pharmaceuticals-plans-to-stop-making-flu-vaccine.html
http://www.nytimes.com/reuters/2013/07/13/sports/cycling/13reuters-cycling-tour-winner.html
http://krugman.blogs.nytimes.com/2011/09/30/ireland-triumphs/
http://www.nytimes.com/2011/04/28/opinion/l28drugs.html
http://query.nytimes.com/gst/abstract.html?res=9503E2D7173AE23BBC4E51DFB3668389649EDE
http://query.nytimes.com/gst/abstract.html?res=9B03E3D8173AE23BBC4B51DFB3668389649EDE
http://query.nytimes.com/gst/abstract.html?res=9B07E4DD1030E43ABC4D53DFB366838B659EDE
http://www.nytimes.com/2011/04/28/opinion/l28drugs.html
http://dealbook.nytimes.com/2009/03/16/astellas-to-end-hostile-bid-for-cv-therapeutics/
http://query.nytimes.com/gst/abstract.html?res=9A06E6DE163EE43ABC4C52DFB2668388649EDEhttp://dealbook.nytimes.com/2006/06/07/novartis-bids-569-million-for-british-drugmaker/
http://www.nytimes.com/2002/03/30/nyregion/c-corrections-501271.html
http://query.nytimes.com/gst/abstract.html?res=9C05E7DC123AE53ABC4B52DFB7668389649EDE
http://query.nytimes.com/gst/abstract.html?res=950DE0DC163DEE3BBC4F51DFB467838D659EDE
http://query.nytimes.com/gst/abstract.html?res=9B01E3D7153EE03BBC4A52DFB467838F659EDE
http://dealbook.nytimes.com/2014/04/06/sun-pharmaceuticals-of-india-to-buy-ranbaxy-a-smaller-rival/
http://krugman.blogs.nytimes.com/2013/12/14/tpp-and-ip-a-brief-note/
http://query.nytimes.com/gst/fullpage.html?res=9C02E2DD1E39F936A35756C0A9659D8B63
http://query.nytimes.com/gst/abstract.html?res=9905E3D81039E03ABC4852DFB566838B629EDE
/data/daily/2005/02/02/253537.sgmlhttp://query.nytimes.com/gst/fullpage.html?res=9C02E2DD1E39F936A35756C0A9659D8B63
http://query.nytimes.com/gst/abstract.html?res=9905E3D81039E03ABC4852DFB566838B629EDE
http://dealbook.nytimes.com/2008/02/28/galderma-buys-collagenex-for-420-million/
http://query.nytimes.com/gst/fullpage.html?res=9E02E5DD1530F930A15751C1A9639C8B63
http://www.nytimes.com/2004/04/22/us/national-briefing-science-and-health-approval-of-parkinson-s-drug.html
http://www.nytimes.com/1993/10/05/business/cangene-corp-reports-earnings-for-year-to-july-31.html
http://www.nytimes.com/reuters/2013/05/09/sports/cycling/09reuters-cycling-giro-winner.html
http://dealbook.nytimes.com/2007/12/20/akela-to-scrap-us-ipo/
http://query.nytimes.com/gst/abstract.html?res=9402E2D9143AE53BBC4850DFB566838F649EDE
http://www.nytimes.com/1992/05/01/business/north-american-biologicals-inc-reports-earnings-for-qtr-to-march-31.htmlhttp://query.nytimes.com/gst/abstract.html?res=9A0DEFDB163AE233A25755C2A96F9C946093D6CF
http://www.nytimes.com/reuters/2012/08/18/sports/cycling/18reuters-cycling-vuelta-winner.html
http://query.nytimes.com/gst/fullpage.html?res=9400EFDB1230F93BA1575BC0A96E9C8B63
http://dealbook.nytimes.com/2006/03/15/danish-drug-developer-raises-48-million/
http://www.nytimes.com/2001/05/12/us/national-briefing-science-and-health-pain-drug-shipments-suspended.html
http://query.nytimes.com/gst/abstract.html?res=9F06E3DE123DEE3ABC4C53DFB166838A679EDE
http://www.nytimes.com/reuters/2014/09/07/sports/cycling/07reuters-cycling-britain.html
http://www.nytimes.com/reuters/2014/09/08/sports/cycling/08reuters-cycling-britain.html
http://www.nytimes.com/2014/10/19/sunday-review/the-ebola-conspiracy-theories.html
http://www.nytimes.com/reuters/2014/09/04/business/04reuters-roche-m-a-chairman.htmlhttp://www.nytimes.com/reuters/2014/02/18/business/18reuters-germany-drugs-analysis.html
http://www.nytimes.com/reuters/2014/09/23/world/africa/23reuters-health-ebola-trials.html
http://www.nytimes.com/2002/11/21/classified/paid-notice-deaths-temple-maurice.html
http://www.legacy.com/Link.asp?I=LS000000606431
http://www.nytimes.com/aponline/2014/01/09/world/asia/ap-as-japan-novartis.html
http://dealbook.nytimes.com/2010/03/03/archimedes-gets-98-million-injection/
http://query.nytimes.com/gst/abstract.html?res=9D05E2DE103FE13ABC4C53DFB566838A679EDE
http://www.nytimes.com/aponline/2012/10/16/sports/ap-cyc-quick-step-leipheimer-fired.html
http://dealbook.nytimes.com/2009/02/24/astellas-still-wants-cv-therapeutics/
http://query.nytimes.com/gst/abstract.html?res=9504E2DA173DE63ABC4952DFB767838C679EDEhttp://www.legacy.com/Link.asp?I=LS000167034421
http://www.nytimes.com/1999/07/20/business/company-news-biochem-buys-back-stock-from-glaxo-wellcome.html
http://query.nytimes.com/gst/abstract.html?res=9503E0DE143BE23BBC4051DFBF668382659EDE
http://query.nytimes.com/gst/abstract.html?res=9F03E4DF103BEF3ABC4D51DFB767838A659EDE
http://www.nytimes.com/2010/04/27/business/global/27deal.html
http://www.nytimes.com/reuters/2013/06/19/business/19reuters-forest-elan.html
http://dealbook.nytimes.com/2007/09/20/maker-of-botox-to-buy-bladder-drug-rival/
http://query.nytimes.com/gst/fullpage.html?res=9505E5DF1E39F937A1575AC0A9629C8B63
http://www.nytimes.com/1996/04/21/style/weddings-nora-k-lee-geoffrey-kanter.html
http://query.nytimes.com/gst/abstract.html?res=9E05E2DC103FE43ABC4B51DFB4668389649EDEhttp://query.nytimes.com/gst/fullpage.html?res=9903E0DB123AF93AA2575AC0A9659D8B63
http://www.nytimes.com/2011/08/27/opinion/empowering-medicare.html
http://dealbook.nytimes.com/2008/04/18/cv-therapuetics-gets-175-million-injection-from-hege-fund/
http://www.nytimes.com/2001/09/02/nyregion/in-business-state-grant-helps-yonkers-upgrade-wiring-in-building.html
http://www.nytimes.com/1999/06/30/business/company-briefs-399914.html
http://www.nytimes.com/reuters/2014/06/11/business/11reuters-novartis-japan.html
http://www.nytimes.com/reuters/2013/08/30/sports/cycling/30reuters-cycling-spain-winner.html
http://www.nytimes.com/reuters/2013/08/24/sports/cycling/24reuters-cycling-vuelta-winner.html
http://www.nytimes.com/1998/10/07/business/the-media-business-advertising-addenda-accounts-217603.html
http://query.nytimes.com/gst/abstract.html?res=9506EFDF1131E23BBC4051DFB467838A649EDEhttp://query.nytimes.com/gst/abstract.html?res=9B03E5DB1430E53BBC4B51DFB3668388659EDE
http://www.nytimes.com/reuters/2013/06/19/business/19reuters-forest-elan.html
http://dealbook.nytimes.com/2007/09/20/maker-of-botox-to-buy-bladder-drug-rival/
http://query.nytimes.com/gst/fullpage.html?res=9505E5DF1E39F937A1575AC0A9629C8B63
http://www.nytimes.com/1996/04/21/style/weddings-nora-k-lee-geoffrey-kanter.html
http://www.nytimes.com/reuters/2013/08/07/business/07reuters-aptalis-tpg.html
http://www.nytimes.com/2002/04/26/us/national-briefing-new-england-massachusetts-store-chain-to-drop-oxycontin.html
http://query.nytimes.com/gst/abstract.html?res=9A00E3DC1E31E03BBC4052DFB667838F659EDE
http://dealbook.nytimes.com/2008/09/02/japanese-drug-maker-swallows-us-rival/
http://dealbook.nytimes.com/2013/05/13/elan-in-deal-on-drug-royalties/http://dealbook.nytimes.com/2008/09/02/japanese-drug-maker-swallows-us-rival/
http://www.nytimes.com/reuters/2013/12/08/business/08reuters-novartis.html
http://dealbook.nytimes.com/2013/05/13/elan-in-deal-on-drug-royalties/
http://query.nytimes.com/gst/fullpage.html?res=9F0DE1DE1530F931A15757C0A96E9C8B63
http://query.nytimes.com/gst/abstract.html?res=9805EED8123DE733A25756C0A9679C946091D6CF
http://www.nytimes.com/reuters/2014/07/07/sports/cycling/07reuters-cycling-road-tour-de-france-results.html
http://dealbook.nytimes.com/2007/11/28/japans-astellas-to-buy-agensys/
http://www.nytimes.com/aponline/2012/11/14/business/ap-us-fiscal-cliff-health-care-summary-box.html
http://dealbook.nytimes.com/2008/05/02/esperion-raises-228-million-after-pfizer-spin-out/
http://www.nytimes.com/reuters/2014/01/08/business/08reuters-novartis-diovan-japan.htmlhttp://dealbook.nytimes.com/2009/09/03/drug-maker-dainippon-to-buy-sepracor-for-26-billion/
http://www.nytimes.com/2005/05/08/fashion/weddings/08carb.html
http://www.nytimes.com/2002/11/20/classified/paid-notice-deaths-temple-maurice.html
http://www.nytimes.com/reuters/2014/09/19/sports/cycling/19reuters-cycling-world.html
http://www.nytimes.com/reuters/2014/07/08/sports/cycling/08reuters-cycling-road-tour-de-france-results.html
http://india.blogs.nytimes.com/2011/09/20/the-battle-over-generic-drugs-continues/
http://dealbook.nytimes.com/2009/02/27/astellas-commences-tender-offer-in-cv-bid/
http://query.nytimes.com/gst/abstract.html?res=9E01E7DC1131EE3BBC4152DFB4678382679EDE
http://query.nytimes.com/gst/abstract.html?res=9F07E4DF123DE731A25752C1A9679D946092D6CF
http://query.nytimes.com/gst/abstract.html?res=9C02EFD91638E33BBC4C52DFB0668388659EDEhttp://www.nytimes.com/reuters/2013/06/11/business/11reuters-elan-royalty.html
http://www.nytimes.com/2013/05/05/sports/cycling/mark-cavendish-leads-in-giro-ditalia.html
http://query.nytimes.com/gst/fullpage.html?res=9803E1DB123AF936A25751C0A9639C8B63
http://query.nytimes.com/gst/abstract.html?res=9D07E6DF143AE633A25757C1A9609C946596D6CF
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-novartis-boltons.html
http://dealbook.nytimes.com/2008/04/28/japanese-drugmaker-buys-stake-in-comentis/
http://query.nytimes.com/gst/abstract.html?res=9804E4DB1031E73BBC4C51DFBE668383649EDE
http://query.nytimes.com/gst/abstract.html?res=9803E4DF1E3EE03BBC4D53DFBE668382659EDE
http://query.nytimes.com/gst/abstract.html?res=9A00E7DC173AE13ABC4951DFB4678383659EDE
http://www.nytimes.com/2002/11/02/business/generic-prilosec-to-be-marketed.htmlhttp://www.nytimes.com/2001/12/23/us/doctor-to-face-us-charges-in-drug-case.html
http://dealbook.nytimes.com/2008/06/11/japans-daiichi-coughs-up-46-billion-for-ranbaxy/
http://www.nytimes.com/2014/10/24/health/without-lucrative-market-potential-ebola-vaccine-was-shelved-for-years.html
http://www.nytimes.com/reuters/2014/09/15/business/15reuters-markets-stocks.html
http://www.nytimes.com/aponline/2013/03/04/business/ap-us-elan-tysabri-dividend.html
http://dealbook.nytimes.com/2010/04/26/charles-river-buys-chinese-drug-research-firm/
http://dealbook.nytimes.com/2013/07/29/perrigo-to-buy-irish-drug-maker-for-6-7-billion/
http://www.nytimes.com/reuters/2014/09/03/sports/03reuters-cycling-spain.html
http://query.nytimes.com/gst/abstract.html?res=9C05EFDD1638EF3BBC4C51DFB0668383649EDE
http://www.nytimes.com/aponline/2014/07/24/health/ap-eu-med-malaria-vaccine.htmlhttp://www.nytimes.com/2001/04/24/nyregion/metro-business-briefing-rohatyn-s-new-venture.html
http://query.nytimes.com/gst/abstract.html?res=950CE6DB113DEF34BC4B51DFBE668389669EDE
http://krugman.blogs.nytimes.com/2013/03/12/the-eurobeatings-will-continue/
http://query.nytimes.com/gst/fullpage.html?res=9900E5DC133CF935A25750C0A9639C8B63
http://www.nytimes.com/1992/12/28/business/the-media-business-advertising-addenda-accounts-132492.html
http://query.nytimes.com/gst/abstract.html?res=9903E7D8123DE63ABC4C52DFB0668388669EDE
http://query.nytimes.com/gst/abstract.html?res=9E0DE5D81F3AEE32A25756C2A9679C946094D6CF
http://query.nytimes.com/gst/abstract.html?res=9B05E3DF123DE733A2575BC2A9639C946695D6CF
http://query.nytimes.com/gst/abstract.html?res=9F0DE7DB1F30EE3ABC4C53DFB5668389639EDE
http://query.nytimes.com/gst/abstract.html?res=9C05EFDD1638EF3BBC4C51DFB0668383649EDE
http://krugman.blogs.nytimes.com/2009/07/16/the-ama-as-good-guys/
http://www.nytimes.com/2000/10/04/business/world-business-briefing-europe-roche-rejects-genentech-sale.html
http://query.nytimes.com/gst/abstract.html?res=9905E1DE153FE03BBC4C53DFB166838D649EDE
http://query.nytimes.com/gst/abstract.html?res=9A03EFDD143CE53ABC4850DFB066838D629EDE
http://query.nytimes.com/gst/abstract.html?res=9E01EEDD173CE53ABC4E52DFB467838E629EDE
http://dealbook.nytimes.com/2008/05/16/as-private-equity-snaps-up-debt-others-stay-away/
http://query.nytimes.com/gst/fullpage.html?res=9F00E1D6133AF933A15753C1A9629C8B63
http://www.nytimes.com/2001/04/24/nyregion/metro-business-briefing-rohatyn-s-new-venture.html
http://query.nytimes.com/gst/abstract.html?res=950CE6DB113DEF34BC4B51DFBE668389669EDE
http://www.nytimes.com/2001/08/19/magazine/l-the-alchemy-of-oxycontin-695785.htmlhttp://topics.nytimes.com/top/news/business/companies/iaso-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/horizon-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/aspenbio-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/china-pharma-holdings-inc/index.html
http://topics.nytimes.com/top/news/business/companies/kite-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/cardiome-pharma-corporation/index.html
http://topics.nytimes.com/top/news/business/companies/scolr-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/nutra-pharma-corporation/index.html
http://topics.nytimes.com/top/news/business/companies/recro-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/targeted-medical-pharma-inc/index.htmlhttp://dealbook.nytimes.com/2014/11/06/drug-maker-perrigo-to-acquire-omega-pharma/
http://topics.nytimes.com/top/news/business/companies/novadel-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/bio-blast-pharma-ltd/index.html
http://topics.nytimes.com/top/news/business/companies/zosano-pharma-corporation/index.html
http://www.nytimes.com/2014/11/11/opinion/big-pharma-and-ebola.html
http://www.nytimes.com/aponline/2014/11/06/business/ap-us-perrigo-omega-acquisition.html
http://www.nytimes.com/reuters/2014/10/20/business/20reuters-omega-actavis.html
http://www.nytimes.com/reuters/2014/10/29/technology/29reuters-google-pharmaceuticals-settlement.html
http://www.nytimes.com/reuters/2014/10/24/business/24reuters-hikma-pharma-warning-fda.html
http://www.nytimes.com/aponline/2014/10/03/business/ap-us-salix-inversion-scuttled.htmlhttp://www.nytimes.com/aponline/2014/09/22/business/ap-us-auxilium-pharmaceuticals-endo-international.html
http://www.nytimes.com/reuters/2014/10/09/business/09reuters-auxilium-pharm-offer-endo-intl.html
http://www.nytimes.com/reuters/2014/10/15/business/15reuters-markets-stocks-europe.html
http://www.nytimes.com/aponline/2014/09/16/business/ap-us-endo-auxilium.html
http://query.nytimes.com/gst/fullpage.html?res=9B01E0D71731F937A35755C0A9609C8B63
http://www.nytimes.com/reuters/2014/09/21/sports/cycling/21reuters-cycling-world-ttt.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320129.html
http://www.nytimes.com/reuters/2014/09/18/business/18reuters-sinclair-results.html
http://www.nytimes.com/reuters/2014/09/23/business/23reuters-markets-stocks-ftse.html
http://www.nytimes.com/2001/02/08/us/national-news-briefs-raids-in-kentucky-aim-at-deadly-new-drug.htmlhttp://www.nytimes.com/2014/07/26/your-money/seeing-a-supersize-yacht-as-a-job-engine-not-a-self-indulgence.html
http://www.nytimes.com/2007/07/21/business/21pharma.html
http://www.nytimes.com/2001/08/07/nyregion/metro-briefing-connecticut-hartford-warning-on-painkiller.html
http://www.nytimes.com/2009/01/24/business/24pharma.html
http://www.nytimes.com/2005/08/27/business/27drug.html
http://www.nytimes.com/2007/05/10/business/11drug-web.html
http://www.nytimes.com/2004/04/14/business/company-news-purdue-pharma-to-cut-nearly-300-jobs-in-connecticut.html
http://www.nytimes.com/2001/11/09/us/national-briefing-south-florida-inquiry-on-painkiller.html
http://www.nytimes.com/reuters/2014/09/16/business/16reuters-auxilium-pharm-offer-endo-intl.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176796.htmlhttp://www.nytimes.com/2004/11/06/business/06drug.html
http://www.nytimes.com/2002/03/30/nyregion/c-corrections-311758.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176788.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176800.html
http://www.nytimes.com/reuters/2014/10/01/business/01reuters-flu-vaccine-analysis.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176770.html
http://www.nytimes.com/2010/12/16/business/16purdue.html
http://www.nytimes.com/2004/05/08/nyregion/city-claims-drug-maker-overcharged-for-painkiller.html
http://www.nytimes.com/2003/08/12/business/generics-shake-up-a-drug-industry.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320145.htmlhttp://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320137.html
http://www.nytimes.com/2001/02/14/opinion/l-pain-relief-for-cancer-898465.html
http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html
http://www.nytimes.com/2001/08/09/us/national-briefing-science-and-health-new-form-for-abused-painkiller.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320110.html
http://www.nytimes.com/1994/11/22/business/biochem-pharma.html
http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html
http://www.nytimes.com/2003/09/04/business/media-business-advertising-maker-oxycontin-painkiller-that-addictive-sponsors.html
http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html
http://www.nytimes.com/2011/06/16/health/16oxy.html/data/daily/2007/10/05/526452.sgml
http://www.nytimes.com/2007/07/20/business/20oxy.html
http://www.nytimes.com/2005/06/08/business/08drug.html
http://www.nytimes.com/2004/04/18/nyregion/worth-noting-ruling-forces-company-to-cut-jobs-in-stamford.html
http://www.nytimes.com/2001/08/13/us/maker-chose-not-to-use-a-drug-abuse-safeguard.html
http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html
http://www.nytimes.com/2011/06/16/health/16oxy.html
http://www.nytimes.com/2007/05/09/business/09purdue.html
http://www.nytimes.com/2001/08/18/opinion/l-abuse-of-oxycontin-756300.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176761.htmlhttp://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176753.html
http://topics.nytimes.com/top/news/business/companies/blackstone-lake-minerals-inc/index.html
http://topics.nytimes.com/top/news/business/companies/marshall-edwards-inc/index.html
http://topics.nytimes.com/top/news/business/companies/nexgen-biofuels-ltd/index.html
http://www.nytimes.com/2014/03/13/business/abuse-resistant-hydrocodone-could-sink-sales-of-new-drug.html
http://www.nytimes.com/2003/10/28/business/world-business-briefing-europe-germany-drug-maker-cuts-outlook.html
http://www.nytimes.com/2007/06/19/business/19drug.html
http://www.nytimes.com/2004/01/06/business/judge-says-maker-of-oxycontin-misled-officials-to-win-patents.html
http://query.nytimes.com/gst/abstract.html?res=9806E5DA123CE23BBC4C52DFB7668382659EDE
http://www.nytimes.com/2007/12/28/us/politics/28oxycontin.htmlhttp://www.nytimes.com/2000/01/20/business/world-business-briefing-europe-basf-pharma-reorganizes.html
http://www.nytimes.com/1996/08/20/business/profits-rise-12.8-at-schwarz-pharma.html
http://www.nytimes.com/1992/02/11/business/market-place-a-drug-flunks-a-stock-collapses.html
http://www.nytimes.com/2007/05/11/business/11drug.html
/data/daily/2004/09/30/138428.sgml
http://query.nytimes.com/gst/abstract.html?res=9400E7DF1238E23BBC4951DFBF66838F649EDE
http://query.nytimes.com/gst/fullpage.html?res=9C01EEDB1F31F935A1575AC0A9609C8B63
http://www.nytimes.com/2005/07/14/health/14asthma.html
http://query.nytimes.com/gst/fullpage.html?res=9505E7DB1531F93BA35755C0A9609C8B63
http://www.nytimes.com/2002/11/06/business/company-news-astrazeneca-to-appeal-us-court-ruling-on-generics.htmlhttp://www.nytimes.com/1999/11/26/business/basf-says-it-may-sell-or-exchange-its-pharmaceuticals-unit.html
http://www.nytimes.com/1992/02/11/nyregion/mother-gets-prison-term-in-fatal-beating-of-boy.html
http://www.nytimes.com/2003/11/05/business/company-said-to-develop-substitute-for-painkiller.html
http://www.nytimes.com/2002/05/30/nyregion/metro-briefing-connecticut-stamford-big-client-for-giuliani-s-company.html
http://www.nytimes.com/1999/06/19/business/company-news-alpharma-adds-german-generic-drug-business.html
http://www.nytimes.com/2008/09/01/business/worldbusiness/02drug.html
http://www.nytimes.com/2000/06/24/business/international-business-aventis-unit-sets-big-investment-biotechnology-start-up.html
http://query.nytimes.com/gst/fullpage.html?res=9B0DE6D7173FF936A15750C0A9639C8B63
http://www.nytimes.com/1992/04/05/business/after-granola-what-lichtwer-s-little-garlic-pills.html
http://www.nytimes.com/1989/02/19/realestate/postings-canadians-in-connecticut-armed-to-fit.htmlhttp://www.nytimes.com/2001/12/12/us/official-faults-drug-company-for-marketing-of-its-painkiller.html
http://www.nytimes.com/2013/04/17/business/fda-bars-generic-oxycontin.html
http://www.nytimes.com/2002/12/12/business/technology-briefing-e-commerce-biovail-buys-2-companies-for-190-million.html
http://dealbook.nytimes.com/2013/05/20/royalty-pharma-raises-bid-for-a-resistant-elan/
http://www.nytimes.com/2002/11/12/business/company-news-drug-tester-rejects-chairman-s-takeover-bid.html
http://www.nytimes.com/2001/06/12/us/national-briefing-mid-atlantic-west-virginia-state-sues-drug-maker.html
http://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.html
http://query.nytimes.com/gst/fullpage.html?res=9B0DE6D7173FF936A15750C0A9639C8B63
http://www.nytimes.com/1992/04/05/business/after-granola-what-lichtwer-s-little-garlic-pills.html
http://www.nytimes.com/1989/02/19/realestate/postings-canadians-in-connecticut-armed-to-fit.htmlhttp://www.nytimes.com/2004/01/07/business/connecticut-to-investigate-oxycontin-maker.html
http://www.nytimes.com/2004/01/13/business/oxycontin-manufacturer-seeks-delay-of-rival-drugs.html
http://www.nytimes.com/1999/07/16/business/company-news-canadian-drug-maker-offers-to-buy-scandipharm.html
http://www.nytimes.com/2002/04/25/business/company-news-vertex-says-arthritis-drug-falls-short-of-expectations.html
http://dealbook.nytimes.com/2010/06/03/astellas-extends-tender-offer-for-osi/
http://dealbook.nytimes.com/2013/06/17/battle-for-elan-in-doubt-after-shareholders-approve-buyback-plan/
http://www.nytimes.com/2013/04/20/opinion/the-loss-of-generic-oxycontin.html
http://www.nytimes.com/2002/10/15/business/company-news-head-of-drug-research-company-asks-to-buy-it.html
http://www.nytimes.com/2000/07/14/business/company-news-king-pharmaceuticals-agrees-to-buy-a-rival.html
http://www.nytimes.com/video/multimedia/100000002838976/big-pharma-braces-for-ma-wave.htmlhttp://query.nytimes.com/gst/abstract.html?res=9902E2DF1630EE3ABC4851DFB366838B699FDE
http://query.nytimes.com/gst/fullpage.html?res=9C03E3D81631F934A25754C0A9619C8B63
http://www.nytimes.com/aponline/2014/02/11/business/ap-us-mallinckrodt-acquisition.html
http://www.nytimes.com/2001/07/26/us/effort-to-cut-a-painkiller-s-use.html
http://www.nytimes.com/2014/07/24/business/fda-approves-pain-drug-meant-to-discourage-abuse.html
http://www.nytimes.com/2002/10/14/business/market-place-astrazeneca-has-won-battle-but-its-war-with-generic-drug-makers.html
http://www.nytimes.com/2001/10/28/us/overdoses-of-painkiller-are-linked-to-282-deaths.html
http://www.nytimes.com/2001/03/05/business/sales-of-painkiller-grew-rapidly-but-success-brought-a-high-cost.html
http://www.nytimes.com/1999/04/18/realestate/in-the-region-connecticut-drug-maker-buys-vacant-gte-building-in-stamford.html
http://www.nytimes.com/1984/01/14/business/monsanto-add-belgian-concern-st-louis-jan-13-ap-monsanto-company-announced-it.htmlhttp://www.nytimes.com/2006/11/24/business/24cancer.html
http://query.nytimes.com/gst/fullpage.html?res=9407E4D81E30F936A15751C1A9629C8B63
http://dealbook.nytimes.com/2010/05/16/osi-to-sell-itself-to-astellas-for-4-billion/
http://www.nytimes.com/1993/09/17/business/company-news-sandoz-in-pact-to-make-drugs-for-immune-system.html
http://www.nytimes.com/2007/12/11/business/worldbusiness/11drug.html
http://query.nytimes.com/gst/abstract.html?res=9504E5DE163FE731A25754C1A96F9C94619FD7CF
http://dealbook.nytimes.com/2013/06/14/elan-puts-itself-up-for-sale/
http://dealbook.nytimes.com/2013/06/06/elan-finds-creative-poison-pill-to-defend-against-a-hostile-bid/
http://www.nytimes.com/2010/05/17/business/global/17osi.html
http://www.nytimes.com/2003/05/28/business/company-news-drug-company-board-says-takeover-offer-is-too-low.htmlhttp://dealbook.nytimes.com/2013/06/07/royalty-pharma-raises-its-bid-for-elan-again/
http://www.nytimes.com/2001/05/01/us/us-asks-painkiller-maker-to-help-curb-wide-abuse.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320153.html
http://dealbook.nytimes.com/2013/02/25/buyout-offer-will-likely-not-end-elans-merger-ambitions/
http://www.nytimes.com/2013/01/16/nyregion/ny-police-to-track-drugstore-robbers-via-decoy-bottles.html
http://www.nytimes.com/2003/12/21/weekinreview/the-public-editor-you-can-stand-on-principle-and-still-stub-a-toe.html
http://www.nytimes.com/2001/01/03/business/world-business-briefing-americas-heart-drug-rights-acquired.html
http://dealbook.nytimes.com/2009/10/13/onyx-pharma-swallows-proteolix/
http://dealbook.nytimes.com/2007/01/02/british-healthcare-firm-sinclair-pharma-plans-ipo/
http://www.nytimes.com/1995/06/06/business/block-to-sell-parts-of-unit.htmlhttp://www.nytimes.com/2004/08/27/business/company-news-merck-of-germany-to-buy-pfizer-generic-drug-unit.html
http://www.nytimes.com/2012/09/01/business/fda-approves-prostate-cancer-drug.html
http://www.nytimes.com/1994/11/24/business/company-news-biochem-drops-sale-of-north-american-vaccine-shares.html
http://www.nytimes.com/1992/10/07/business/continental-pharma-reports-earnings-for-year-to-july-31.html
http://www.nytimes.com/2014/01/29/health/drug-shows-promise-in-advanced-prostate-cancer-when-used-before-chemotherapy.html
http://www.nytimes.com/2003/07/26/business/company-news-mgi-pharma-wins-fda-approval-for-antinausea-drug.html
http://www.nytimes.com/reuters/2014/05/26/business/26reuters-china-pharmaceuticals-margins.html
http://www.nytimes.com/1992/10/01/business/biochem-pharma-reports-earnings-for-qtr-to-july-31.html
http://www.nytimes.com/aponline/2013/02/25/business/ap-us-royalty-pharma-elan.html
http://www.nytimes.com/aponline/2013/02/01/business/ap-us-kalobios-pharma-ipo.htmlhttp://www.nytimes.com/aponline/2012/12/31/us/ap-us-hgh-growing-use.html
http://www.nytimes.com/reuters/2014/04/30/business/30reuters-drug-britain-scientists.html
http://www.nytimes.com/2001/07/29/weekinreview/ideas-trends-big-pharma-ogles-yasgur-s-farm.html
http://www.nytimes.com/1993/10/05/business/continental-pharma-reports-earnings-for-year-to-july-31.html
http://www.nytimes.com/2003/12/21/nyregion/li-work.html
http://www.nytimes.com/aponline/2013/05/28/business/ap-us-astrazeneca-acquisition.html
http://dealbook.nytimes.com/2010/10/11/chinese-pharma-set-to-raise-741-million/
http://dealbook.nytimes.com/2009/12/08/apax-buys-pharma-support-firm-marken/
http://dealbook.nytimes.com/2009/05/18/takeda-swallos-idm-pharma-for-around-70-million/
http://www.nytimes.com/1993/04/13/business/company-news-merck-plans-to-expand-its-generic-drug-division.htmlhttp://www.nytimes.com/1992/08/06/business/company-news-american-home-products-buying-german-drug-concern.html
http://www.nytimes.com/aponline/2014/06/20/business/ap-us-ipo-roundup-pricing.html
http://www.nytimes.com/reuters/2014/05/12/business/12reuters-lumena-shire.html
http://www.nytimes.com/1992/04/03/business/biochem-pharma-reports-earnings-for-year-to-jan-31.html
http://www.nytimes.com/reuters/2014/05/24/business/24reuters-china-pharmaceuticals-margins.html
http://www.nytimes.com/aponline/2012/08/06/us/ap-us-teva-pharma-sec-investigation.html
http://www.nytimes.com/1992/06/22/business/continental-pharma-reports-earnings-for-qtr-to-april-30.html
http://dealbook.nytimes.com/2013/06/18/royalty-pharma-drops-bid-for-elan/
http://www.nytimes.com/aponline/2014/04/25/business/ap-us-prestige-brands-acquisition.html
http://www.nytimes.com/aponline/2012/12/21/us/ap-us-hgh-growing-use.htmlhttp://www.nytimes.com/reuters/2012/09/16/business/16reuters-allianceboots-china-stake.html
http://www.nytimes.com/1993/12/24/business/continental-pharma-reports-earnings-for-qtr-to-oct-31.html
http://www.nytimes.com/reuters/2012/09/11/business/11reuters-india-fdi.html
http://www.nytimes.com/1995/12/22/business/international-briefs-smithkline-acquisition.html
http://www.nytimes.com/2009/12/13/business/13drug.html
http://www.nytimes.com/aponline/2013/06/07/business/ap-us-elan-royalty-pharma-summary-box.html
http://dealbook.nytimes.com/2013/02/25/royalty-pharma-proposes-to-buy-elan-for-6-6-billion/
http://dealbook.nytimes.com/2009/08/21/adamas-completes-40-million-round/
http://www.nytimes.com/aponline/2014/05/13/business/ap-us-allergan-valeant.html
http://www.nytimes.com/reuters/2012/11/12/world/europe/12reuters-croatia-pharmaceuticals-bribery.htmlhttp://www.nytimes.com/1986/03/16/us/tainted-anticoagulant-drug-for-treating-cancer-recalled.html
http://www.nytimes.com/reuters/2013/03/06/business/06reuters-royaltypharma-elan.html
http://www.nytimes.com/1991/05/23/business/johnson-merck-to-buy-german-drug-unit.html
http://www.nytimes.com/2012/09/01/business/fda-approves-prostate-cancer-drug.html
http://www.nytimes.com/2000/12/12/business/technology-shire-offers-4-billion-for-biochem.html
http://www.nytimes.com/1992/09/05/business/merck-establishes-division-to-produce-a-generic-drug.html
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-novartis.html
http://www.nytimes.com/reuters/2013/02/11/business/11reuters-perrigo-acquisition.html
http://www.nytimes.com/aponline/2012/10/15/us/ap-us-wall-street-close.html
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-teva-pharma-sec-investigation-summary-box.htmlhttp://www.nytimes.com/2008/09/02/business/worldbusiness/02fashion.html
http://www.nytimes.com/2004/02/24/business/company-news-merck-plans-to-buy-developer-of-cancer-drug.html
http://www.nytimes.com/2000/10/05/business/drug-company-buys-distributor.html
http://www.nytimes.com/1986/07/08/business/bausch-lomb-plans-acquisition.html
http://www.nytimes.com/2007/05/08/nyregion/08mbrfs-drug.html
http://www.nytimes.com/2003/04/12/business/company-news-chairman-is-buying-quintiles-transnational.html
http://www.nytimes.com/2013/11/15/business/chicago-reviews-marketing-by-makers-of-narcotic-painkillers.html
http://www.nytimes.com/2001/07/21/business/world-business-briefing-europe-britain-skin-care-deal.html
http://www.nytimes.com/1992/09/08/business/merck-sets-generic-drug-sales.html
http://www.nytimes.com/reuters/2012/08/20/business/20reuters-novartis-india.htmlhttp://www.nytimes.com/reuters/2013/06/10/business/10reuters-dealtalk-drugmakers-ireland.html
http://www.nytimes.com/aponline/2013/04/22/business/ap-eu-ireland-elan.html
http://www.nytimes.com/aponline/2013/03/21/business/ap-us-enanta-pharmaceuticals-ipo.html
http://www.nytimes.com/aponline/2013/06/07/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/aponline/2013/04/15/business/ap-us-royalty-pharma-elan-offer.html
http://dealbook.nytimes.com/2012/04/11/takeda-of-japan-buys-url-pharma-for-800-million/
http://dealbook.nytimes.com/2008/02/07/3i-takes-another-shot-a-pharma-with-api-deal/
http://www.nytimes.com/reuters/2014/05/06/business/06reuters-healthcare-m-a-factbox.html
http://www.nytimes.com/reuters/2012/08/19/business/19reuters-novartis-india.html
http://www.nytimes.com/1992/04/03/business/continental-pharma-reports-earnings-for-qtr-to-jan-31.htmlhttp://www.nytimes.com/reuters/2013/06/10/business/10reuters-dealtalk-drugmakers-ireland.html
http://www.nytimes.com/aponline/2013/04/22/business/ap-eu-ireland-elan.html
http://www.nytimes.com/aponline/2013/03/21/business/ap-us-enanta-pharmaceuticals-ipo.html
http://www.nytimes.com/aponline/2013/09/19/business/ap-us-acceleron-pharma-ipo-mover.html
http://www.nytimes.com/aponline/2013/07/18/business/ap-us-oncomed-pharma-ipo-pricing.html
http://www.nytimes.com/2000/09/27/business/company-news-novartis-pharma-and-biotransplant-in-alliance.html
http://www.nytimes.com/2014/08/25/us/chicago-and-2-california-counties-sue-drug-companies-over-painkiller-marketing.html
http://www.nytimes.com/aponline/2013/06/19/world/europe/ap-eu-eu-generic-medicine.html
http://www.nytimes.com/reuters/2013/03/04/business/04reuters-elan-royalty.html
http://dealbook.nytimes.com/2007/11/19/zosano-pharma-swallows-90-million/http://www.nytimes.com/reuters/2013/08/01/sports/cycling/01reuters-cycling-omegapharma-uran.html
http://www.nytimes.com/reuters/2013/07/23/us/23reuters-gsk-china.html
http://www.nytimes.com/reuters/2013/07/13/sports/cycling/13reuters-cycling-tour.html
http://www.nytimes.com/reuters/2013/04/11/business/11reuters-royaltypharma-elan.html
/data/daily/2004/09/02/845396.sgml
http://www.nytimes.com/2001/03/22/business/the-media-business-advertising-addenda-purdue-pharma-has-new-agency.html
http://www.nytimes.com/2013/01/02/health/drug-makers-losing-a-bid-to-foil-generic-painkillers.html
http://www.nytimes.com/1993/12/17/business/company-news-ciba-geigy-in-china.html
http://www.nytimes.com/aponline/2013/06/18/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/reuters/2013/03/27/business/27reuters-india-drugs-glivec.htmlhttp://dealbook.nytimes.com/2010/02/16/quintiles-expands-stake-in-big-pharma/
http://query.nytimes.com/gst/fullpage.html?res=9801E7DD1231F931A25757C0A9649D8B63
http://www.nytimes.com/1995/05/10/business/al-pharma-alon-reports-earnings-for-qtr-to-mar-31.html
http://www.nytimes.com/2005/06/24/health/24drugs.html
http://www.nytimes.com/reuters/2014/06/01/business/01reuters-shire-m-a-nps.html
http://www.nytimes.com/reuters/2013/12/15/business/15reuters-markets-india-shares.html
http://www.nytimes.com/aponline/2013/06/27/business/ap-us-fda-online-pharmacies-summary-box.html
http://www.nytimes.com/aponline/2013/05/20/business/ap-us-elan-royalty-pharma-offer.html
http://dealbook.nytimes.com/2006/07/19/gilead-acquires-corus-pharma-for-365-million/
http://www.nytimes.com/reuters/2014/04/07/business/07reuters-daiichi-sankyo-ranbaxy-sunpharma-profit.htmlhttp://www.nytimes.com/reuters/2012/11/05/business/05reuters-abbott.html
http://www.nytimes.com/reuters/2013/08/02/business/02reuters-india-gsk.html
http://www.nytimes.com/reuters/2013/09/12/business/12reuters-india-drugs-analysis.html
http://www.nytimes.com/reuters/2014/01/17/world/17reuters-safrica-pharma.html
http://www.nytimes.com/1990/04/05/business/continental-pharma-cryosan-inc-reports-earnings-for-qtr-to-jan-31.html
http://query.nytimes.com/gst/abstract.html?res=9407E2D71638EF3BBC4851DFB7668382649EDE
http://www.nytimes.com/reuters/2013/02/26/business/26reuters-royaltypharma-endo.html
http://www.nytimes.com/1992/01/02/business/continental-pharma-cryosan-reports-earnings-for-qtr-to-oct-31.html
http://www.nytimes.com/1989/07/11/business/continental-pharma-cryosan-inc-reports-earnings-for-qtr-to-april-30.html
http://www.nytimes.com/reuters/2014/07/28/business/28reuters-reckitt-benc-grp-pharmaceuticals.htmlhttp://www.nytimes.com/aponline/2014/02/07/us/politics/ap-us-sports-doping-drugmakers.html
http://www.nytimes.com/reuters/2014/02/02/business/02reuters-novartis-jobs.html
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-k-v-pharma-bankruptcy.html
http://www.nytimes.com/1994/11/02/business/al-pharma-inc-alon-reports-earnings-for-qtr-to-sept-30.html
http://www.nytimes.com/reuters/2014/04/06/business/06reuters-daiichi-sankyo-ranbaxy-sunpharma.html
http://www.nytimes.com/reuters/2014/03/13/business/13reuters-sun-pharma-india-fda.html
http://www.nytimes.com/1995/08/03/business/al-pharma-alon-reports-earnings-for-2d-qtr-to-jun-30.html
http://www.nytimes.com/1992/06/29/business/biochem-pharma-inc-reports-earnings-for-qtr-to-april-30.html
http://www.nytimes.com/aponline/2014/04/07/business/ap-as-india-sun-pharma-ranbaxy.html
http://www.nytimes.com/aponline/2012/08/06/business/ap-us-k-v-pharma-bankruptcy-summary-box.htmlhttp://www.nytimes.com/2010/06/20/books/review/Scarf-t.html
http://www.nytimes.com/reuters/2014/06/12/business/12reuters-china-pharmaceuticals.html
http://www.nytimes.com/2003/09/11/business/drug-panel-rejects-pleas-to-curb-sales-of-a-widely-abused-painkiller.html
http://www.nytimes.com/reuters/2013/09/05/business/05reuters-china-bribery-probe.html
http://www.nytimes.com/reuters/2013/06/09/business/09reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/04/02/business/02reuters-india-pharmaceuticals.html
http://www.nytimes.com/reuters/2014/07/12/business/12reuters-merck-deals.html
http://www.nytimes.com/reuters/2014/04/29/business/29reuters-sanofi-earnings.html
http://www.nytimes.com/reuters/2014/03/12/business/12reuters-bayer-outlook.html
http://www.nytimes.com/2013/02/05/science/a-look-at-bad-pharma-and-science-as-performance.htmlhttp://www.nytimes.com/reuters/2014/06/25/business/25reuters-markets-india-shares.html
http://www.nytimes.com/reuters/2014/04/23/business/23reuters-novartis-gsk-assetswaps.html
http://www.nytimes.com/aponline/2014/04/10/business/ap-us-adamas-pharma-ipo.html
http://www.nytimes.com/reuters/2014/03/19/business/19reuters-horizonpharma-acquisition.html
http://dealbook.nytimes.com/2014/01/08/forest-labs-to-buy-specialty-drug-maker-for-2-9-billion/
http://www.nytimes.com/reuters/2013/12/19/business/19reuters-markets-britain-stocks.html
http://dealbook.nytimes.com/2010/09/10/shanghai-pharma-plans-1-2-billion-hong-kong-i-p-o/
http://www.nytimes.com/1992/12/15/business/continental-pharma-cryosan-reports-earnings-for-qtr-to-oct-31.html
http://www.nytimes.com/2003/09/04/business/company-news-canadian-company-buys-drug-rights-from-abbott-labs.html
http://www.nytimes.com/2002/04/15/us/oxycontin-deaths-may-top-early-count.htmlhttp://www.nytimes.com/1992/12/15/business/continental-pharma-cryosan-reports-earnings-for-qtr-to-oct-31.html
http://www.nytimes.com/reuters/2014/06/17/business/17reuters-gw-pharma.html
http://dealbook.nytimes.com/2007/12/10/japans-eisai-to-cough-up-39-billion-for-mgi-pharma/
http://www.nytimes.com/2004/01/23/business/us-report-faults-maker-of-oxycontin.html
http://www.nytimes.com/2002/10/12/business/ruling-backs-some-patents-on-a-leading-ulcer-drug.html
http://dealbook.nytimes.com/2009/12/10/ex-ropes-gray-lawyer-pleads-guilty-in-galleon-case/
http://www.nytimes.com/reuters/2014/08/06/business/06reuters-markets-britain-stocks.html
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-usa-healthcare-mergers.html
http://www.nytimes.com/2000/10/29/magazine/the-way-we-live-now-10-29-00-pro-pharma.html
http://www.nytimes.com/reuters/2014/05/22/business/22reuters-roche-hldg-china.htmlhttp://www.nytimes.com/reuters/2014/05/04/business/04reuters-pharmaceuticals-sales.html
http://www.nytimes.com/reuters/2014/02/12/business/12reuters-reckittbenckiser-results.html
http://www.nytimes.com/1995/03/29/business/al-pharma-alon-reports-earnings-for-qtr-to-dec-31.html
http://www.nytimes.com/reuters/2013/07/03/business/03reuters-alliancepharma-interview.html
http://www.nytimes.com/reuters/2013/06/14/business/14reuters-royaltpharma-response.html
http://www.nytimes.com/2001/12/10/us/at-painkiller-trouble-spot-signs-seen-as-alarming-didn-t-alarm-drug-s-maker.html
http://www.nytimes.com/1994/04/28/business/company-news-merck-to-add-to-generic-line-of-drugs.html
http://query.nytimes.com/gst/abstract.html?res=9400E5DE143BE53ABC4C51DFB467838C649EDE
http://query.nytimes.com/gst/abstract.html?res=9C06E5DB103EE23BBC4B51DFBF66838C649EDE
http://www.nytimes.com/reuters/2013/09/18/business/18reuters-china-pharma-sales-analysis.htmlhttp://www.nytimes.com/reuters/2013/05/31/business/31reuters-meda-sunpharma.html
http://www.nytimes.com/reuters/2013/06/12/business/12reuters-pfizer-patent.html
http://www.nytimes.com/video/business/100000001643644/business-day-live-july-3-2012.html
http://www.nytimes.com/reuters/2013/07/29/business/29reuters-valeant-jobs.html
http://www.nytimes.com/2003/12/24/business/commercial-real-estate-regional-market-westchester-new-life-science-complex-for.html
http://www.nytimes.com/2004/03/24/business/company-news-fda-approves-generic-versions-of-oxycontin.html
http://www.nytimes.com/reuters/2014/04/09/business/09reuters-ranbaxy-sunpharma.html
http://www.nytimes.com/reuters/2014/04/07/business/07reuters-daiichi-sankyo-ranbaxy-sunpharma.html
http://dealbook.nytimes.com/2010/03/05/putting-high-takeover-premiums-in-perspective/
http://www.nytimes.com/reuters/2014/05/05/business/05reuters-ranbaxy-lab-sun-pharma-silverstreet.htmlhttp://query.nytimes.com/gst/abstract.html?res=990DE1DB1E39E134BC4A51DFB2668383679EDE
http://www.nytimes.com/video/2012/07/03/business/100000001643644/business-day-live-july-3-2012.html
http://www.nytimes.com/2008/03/08/world/europe/08heparin.html
http://dealbook.nytimes.com/2010/01/27/kurland-pleads-guilty-in-galleon-insider-case/
http://dealbook.nytimes.com/2010/01/27/kurland-will-not-cooperate-in-galleon-case/
http://dealbook.nytimes.com/2011/05/18/ex-diamondback-manager-pleaded-guilty-to-insider-trading/
http://dealbook.nytimes.com/2010/06/09/caseys-general-stores-loves-iowa/
http://query.nytimes.com/gst/abstract.html?res=9C0DE1D81539E433A25750C1A9629C946196D6CF
http://www.nytimes.com/2006/12/28/business/28generic.html
http://www.nytimes.com/2010/03/05/business/05views.htmlhttp://www.nytimes.com/reuters/2014/10/20/business/20reuters-sigma-tau-m-a-alfa.html
http://dealbook.nytimes.com/2010/03/22/the-price-of-goofs-in-deal-making/
http://www.nytimes.com/2005/04/20/theater/20place.html
http://www.nytimes.com/2014/11/15/world/asia/india-sterilization-deaths-linked-to-antibiotics-rat-poison.html
http://query.nytimes.com/gst/abstract.html?res=9E0DE3D8173BE430A75750C1A9679D946196D6CF
http://dealbook.nytimes.com/2010/03/05/another-deal-grab-bag-astellas-cf-airgas-and-more/
http://dealbook.nytimes.com/2012/07/03/business-day-live-glaxo-to-pay-3-billion-in-fines/
http://www.nytimes.com/aponline/2014/11/15/world/asia/ap-as-india-sterilization-deaths.html
http://dealbook.nytimes.com/2010/04/01/the-pace-of-deal-making-picks-up/
http://www.nytimes.com/reuters/2014/08/30/sports/cycling/30reuters-cycling-belgium-death.htmlhttp://www.nytimes.com/reuters/2014/10/22/business/22reuters-kremersurban-m-a-adventavista.html
http://dealbook.nytimes.com/2010/04/05/gazing-into-the-crystal-ball-for-april/
http://www.nytimes.com/video/multimedia/100000002986933/asia-day-ahead-watch-out-for-the-ipo-effect.html
http://www.nytimes.com/video/multimedia/100000002858721/az-spurns-pfizer-bayermerck-deal-nears.html
http://www.nytimes.com/video/multimedia/100000002810736/cautionary-tale-for-japan-ma-in-ranbaxy-fail.html
http://dealbook.nytimes.com/2014/11/17/pfizer-to-pay-up-to-2-9-billion-in-cancer-drug-deal-with-merck-of-germany/
http://www.nytimes.com/video/multimedia/100000003008328/abbvie-clinches-shire-deal.html
http://query.nytimes.com/gst/abstract.html?res=990DE4DA123DE333A25755C0A9619C946191D6CF
http://query.nytimes.com/gst/abstract.html?res=9503EFD9103DE03ABC4953DFBE668382659EDE
http://www.nytimes.com/2002/02/26/us/national-briefing-rockies-montana-suit-against-drug-companies.htmlhttp://www.nytimes.com/reuters/2014/09/08/sports/cycling/08reuters-cycling-spain-fight.html
http://www.nytimes.com/aponline/2014/11/14/world/asia/ap-as-india-sterilization-deaths.html
http://dealbook.nytimes.com/2007/02/02/hospira-seals-deal-for-mayne/
http://dealbook.nytimes.com/2010/05/24/behind-the-trends-in-an-m-a-uptick/
http://www.nytimes.com/aponline/2014/10/30/us/ap-us-nfl-drug-lawsuit.html
http://www.nytimes.com/2014/10/03/movies/the-culture-high-explores-marijuana-decriminalization.html
http://www.nytimes.com/reuters/2014/09/24/business/24reuters-markets-stocks-usa.html
http://www.nytimes.com/video/multimedia/100000002998939/shire-ready-to-recommend-higher-abbvie-bid.html
http://query.nytimes.com/gst/abstract.html?res=9F0CE7DA1338E53BBC4A53DFB767838C679EDE
http://www.nytimes.com/reuters/2014/11/03/business/03reuters-covance-m-a-laboratory-corp.htmlhttp://query.nytimes.com/gst/abstract.html?res=9C0DE3D61F3CE73ABC4151DFB467838B659EDE
http://www.nytimes.com/2012/10/17/sports/cycling/levi-leipheimer-dropped-from-cycling-team.html
http://query.nytimes.com/gst/abstract.html?res=9802E3DA1638E33BBC4950DFB3668388659EDE
http://query.nytimes.com/gst/abstract.html?res=9F01E3D91239E632A25756C0A9679C946794D6CF
http://www.nytimes.com/reuters/2014/09/22/business/22reuters-merck-sigma-aldrich.html
http://query.nytimes.com/gst/abstract.html?res=9905E4D8113AE53BBC4B52DFB667838E649EDE
http://query.nytimes.com/gst/abstract.html?res=9A06E1DE133BE13ABC4A53DFB667838A679EDE
http://query.nytimes.com/gst/abstract.html?res=9A05E5DA173AE33BBC4F51DFB266838A659EDE
http://query.nytimes.com/gst/abstract.html?res=9F02E5DC1031E63ABC4C53DFB467838C649EDE
http://query.nytimes.com/gst/abstract.html?res=9500EFDC163AE23BBC4053DFB5668389649EDEhttp://www.nytimes.com/2014/08/31/sports/cycling/valverde-keeps-lead-at-vuelta-a-espaa.html
http://www.nytimes.com/2005/07/19/business/19pharma.html
http://www.nytimes.com/reuters/2013/06/10/business/10reuters-elan-sharebuyback.html
http://www.nytimes.com/aponline/2014/10/15/us/politics/ap-us-supreme-court-generic-drug-dispute.html
http://www.nytimes.com/reuters/2014/10/15/us/politics/15reuters-usa-court-teva-arguments.html
http://query.nytimes.com/gst/abstract.html?res=9E02E0DF1E30EE32A25752C1A9619C946694D6CF
http://www.nytimes.com/reuters/2014/10/01/world/asia/01reuters-aids-india.html
http://www.nytimes.com/reuters/2014/09/02/sports/cycling/02reuters-cycling-spain.html
http://www.nytimes.com/aponline/2013/02/04/us/politics/ap-us-fda-cancer-drug.html
http://www.nytimes.com/reuters/2014/11/13/world/asia/13reuters-india-health-sterilisation.htmlhttp://www.nytimes.com/reuters/2014/11/05/business/05reuters-health-ageing-drugmakers-analysis.html
http://query.nytimes.com/gst/abstract.html?res=9B00E1D8163BEF3ABC4950DFB7668388629EDE
http://www.nytimes.com/reuters/2014/10/07/world/africa/07reuters-health-ebola-pentagon.html
http://www.nytimes.com/1995/03/08/business/company-briefs-222895.html
http://query.nytimes.com/gst/abstract.html?res=9C0CEEDF143BE43BBC4051DFB2668389669EDE
http://query.nytimes.com/gst/abstract.html?res=9F01E6DE1F3DE733A25753C3A9649D946091D6CF
http://query.nytimes.com/gst/abstract.html?res=9B0CE1DB143CE43ABC4F52DFB766838F649EDE
http://www.nytimes.com/2000/09/29/business/company-news-king-pharmaceuticals-plans-to-stop-making-flu-vaccine.html
http://www.nytimes.com/reuters/2013/07/13/sports/cycling/13reuters-cycling-tour-winner.html
http://krugman.blogs.nytimes.com/2011/09/30/ireland-triumphs/http://www.nytimes.com/2011/04/28/opinion/l28drugs.html
http://query.nytimes.com/gst/abstract.html?res=9503E2D7173AE23BBC4E51DFB3668389649EDE
http://query.nytimes.com/gst/abstract.html?res=9B03E3D8173AE23BBC4B51DFB3668389649EDE
http://query.nytimes.com/gst/abstract.html?res=9B07E4DD1030E43ABC4D53DFB366838B659EDE
http://www.nytimes.com/2011/04/28/opinion/l28drugs.html
http://dealbook.nytimes.com/2009/03/16/astellas-to-end-hostile-bid-for-cv-therapeutics/
http://query.nytimes.com/gst/abstract.html?res=9A06E6DE163EE43ABC4C52DFB2668388649EDE
http://www.nytimes.com/aponline/2014/10/26/us/ap-us-ebola-pharma-opportunity.html
http://www.nytimes.com/reuters/2014/08/22/sports/cycling/22reuters-cycling-britain-chavanel.html
http://dealbook.nytimes.com/2006/06/07/novartis-bids-569-million-for-british-drugmaker/http://www.nytimes.com/2002/03/30/nyregion/c-corrections-501271.html
http://query.nytimes.com/gst/abstract.html?res=9C05E7DC123AE53ABC4B52DFB7668389649EDE
http://query.nytimes.com/gst/abstract.html?res=950DE0DC163DEE3BBC4F51DFB467838D659EDE
http://query.nytimes.com/gst/abstract.html?res=9B01E3D7153EE03BBC4A52DFB467838F659EDE
http://www.nytimes.com/reuters/2014/10/03/us/politics/03reuters-usa-court-business-cases-factbox.html
/data/daily/2005/02/02/253537.sgml
http://query.nytimes.com/gst/abstract.html?res=9B0DE1D61F3DEF3ABC4852DFB066838B679EDE
http://query.nytimes.com/gst/abstract.html?res=9D02E5DC1438E333A25757C0A9629C946294D6CF
http://dealbook.nytimes.com/2014/04/06/sun-pharmaceuticals-of-india-to-buy-ranbaxy-a-smaller-rival/
http://krugman.blogs.nytimes.com/2013/12/14/tpp-and-ip-a-brief-note/http://query.nytimes.com/gst/fullpage.html?res=9C02E2DD1E39F936A35756C0A9659D8B63
http://query.nytimes.com/gst/abstract.html?res=9905E3D81039E03ABC4852DFB566838B629EDE
http://dealbook.nytimes.com/2008/02/28/galderma-buys-collagenex-for-420-million/
http://query.nytimes.com/gst/fullpage.html?res=9E02E5DD1530F930A15751C1A9639C8B63
http://www.nytimes.com/2004/04/22/us/national-briefing-science-and-health-approval-of-parkinson-s-drug.html
http://www.nytimes.com/1993/10/05/business/cangene-corp-reports-earnings-for-year-to-july-31.html
http://www.nytimes.com/reuters/2013/05/09/sports/cycling/09reuters-cycling-giro-winner.html
http://dealbook.nytimes.com/2007/12/20/akela-to-scrap-us-ipo/
http://query.nytimes.com/gst/abstract.html?res=9402E2D9143AE53BBC4850DFB566838F649EDE
http://www.nytimes.com/1992/05/01/business/north-american-biologicals-inc-reports-earnings-for-qtr-to-march-31.htmlhttp://query.nytimes.com/gst/abstract.html?res=9A0DEFDB163AE233A25755C2A96F9C946093D6CF
http://www.nytimes.com/reuters/2012/08/18/sports/cycling/18reuters-cycling-vuelta-winner.html
http://query.nytimes.com/gst/fullpage.html?res=9400EFDB1230F93BA1575BC0A96E9C8B63
http://dealbook.nytimes.com/2006/03/15/danish-drug-developer-raises-48-million/
http://www.nytimes.com/2001/05/12/us/national-briefing-science-and-health-pain-drug-shipments-suspended.html
http://query.nytimes.com/gst/abstract.html?res=9F06E3DE123DEE3ABC4C53DFB166838A679EDE
http://www.nytimes.com/reuters/2014/09/07/sports/cycling/07reuters-cycling-britain.html
http://www.nytimes.com/reuters/2014/09/08/sports/cycling/08reuters-cycling-britain.html
http://www.nytimes.com/2014/10/19/sunday-review/the-ebola-conspiracy-theories.html
http://www.nytimes.com/reuters/2014/02/18/business/18reuters-germany-drugs-analysis.htmlhttp://www.nytimes.com/2002/11/21/classified/paid-notice-deaths-temple-maurice.html
http://www.legacy.com/Link.asp?I=LS000000606431
http://www.nytimes.com/reuters/2014/09/04/business/04reuters-roche-m-a-chairman.html
http://dealbook.nytimes.com/2010/03/03/archimedes-gets-98-million-injection/
http://query.nytimes.com/gst/abstract.html?res=9D05E2DE103FE13ABC4C53DFB566838A679EDE
http://www.nytimes.com/aponline/2014/01/09/world/asia/ap-as-japan-novartis.html
http://www.nytimes.com/reuters/2014/09/23/world/africa/23reuters-health-ebola-trials.html
http://www.nytimes.com/aponline/2012/10/16/sports/ap-cyc-quick-step-leipheimer-fired.html
http://dealbook.nytimes.com/2009/02/24/astellas-still-wants-cv-therapeutics/
http://query.nytimes.com/gst/abstract.html?res=9504E2DA173DE63ABC4952DFB767838C679EDEhttp://www.legacy.com/Link.asp?I=LS000167034421
http://www.nytimes.com/1999/07/20/business/company-news-biochem-buys-back-stock-from-glaxo-wellcome.html
http://query.nytimes.com/gst/abstract.html?res=9503E0DE143BE23BBC4051DFBF668382659EDE
http://query.nytimes.com/gst/abstract.html?res=9F03E4DF103BEF3ABC4D51DFB767838A659EDE
http://www.nytimes.com/reuters/2013/06/19/business/19reuters-forest-elan.html
http://dealbook.nytimes.com/2007/09/20/maker-of-botox-to-buy-bladder-drug-rival/
http://query.nytimes.com/gst/fullpage.html?res=9505E5DF1E39F937A1575AC0A9629C8B63
http://www.nytimes.com/1996/04/21/style/weddings-nora-k-lee-geoffrey-kanter.html
http://query.nytimes.com/gst/abstract.html?res=9E05E2DC103FE43ABC4B51DFB4668389649EDE
http://query.nytimes.com/gst/fullpage.html?res=9903E0DB123AF93AA2575AC0A9659D8B63http://www.nytimes.com/reuters/2013/08/30/sports/cycling/30reuters-cycling-spain-winner.html
http://www.nytimes.com/reuters/2013/08/24/sports/cycling/24reuters-cycling-vuelta-winner.html
http://www.nytimes.com/1998/10/07/business/the-media-business-advertising-addenda-accounts-217603.html
http://query.nytimes.com/gst/abstract.html?res=9506EFDF1131E23BBC4051DFB467838A649EDE
http://query.nytimes.com/gst/abstract.html?res=9B03E5DB1430E53BBC4B51DFB3668388659EDE
http://query.nytimes.com/gst/fullpage.html?res=9903E0DB123AF93AA2575AC0A9659D8B63
http://www.nytimes.com/2011/08/27/opinion/empowering-medicare.html
http://dealbook.nytimes.com/2008/04/18/cv-therapuetics-gets-175-million-injection-from-hege-fund/
http://www.nytimes.com/2001/09/02/nyregion/in-business-state-grant-helps-yonkers-upgrade-wiring-in-building.html
http://www.nytimes.com/1999/06/30/business/company-briefs-399914.htmlhttp://www.nytimes.com/reuters/2013/08/24/sports/cycling/24reuters-cycling-vuelta-winner.html
http://www.nytimes.com/1998/10/07/business/the-media-business-advertising-addenda-accounts-217603.html
http://query.nytimes.com/gst/abstract.html?res=9506EFDF1131E23BBC4051DFB467838A649EDE
http://query.nytimes.com/gst/abstract.html?res=9B03E5DB1430E53BBC4B51DFB3668388659EDE
http://www.nytimes.com/2010/04/27/business/global/27deal.html
http://www.nytimes.com/reuters/2013/08/07/business/07reuters-aptalis-tpg.html
http://www.nytimes.com/2002/04/26/us/national-briefing-new-england-massachusetts-store-chain-to-drop-oxycontin.html
http://query.nytimes.com/gst/abstract.html?res=9A00E3DC1E31E03BBC4052DFB667838F659EDE
http://www.nytimes.com/reuters/2013/02/08/sports/cycling/08reuters-cycling-qatar-cavendish.html
http://www.nytimes.com/reuters/2013/07/22/business/22reuters-markets-britain-stocks.htmlhttp://dealbook.nytimes.com/2008/09/02/japanese-drug-maker-swallows-us-rival/
http://www.nytimes.com/reuters/2013/12/08/business/08reuters-novartis.html
http://dealbook.nytimes.com/2013/05/13/elan-in-deal-on-drug-royalties/
http://query.nytimes.com/gst/fullpage.html?res=9F0DE1DE1530F931A15757C0A96E9C8B63
http://query.nytimes.com/gst/abstract.html?res=9805EED8123DE733A25756C0A9679C946091D6CF
http://www.nytimes.com/reuters/2014/07/07/sports/cycling/07reuters-cycling-road-tour-de-france-results.html
http://dealbook.nytimes.com/2007/11/28/japans-astellas-to-buy-agensys/
http://www.nytimes.com/aponline/2012/11/14/business/ap-us-fiscal-cliff-health-care-summary-box.html
http://dealbook.nytimes.com/2008/05/02/esperion-raises-228-million-after-pfizer-spin-out/
http://www.nytimes.com/reuters/2014/01/08/business/08reuters-novartis-diovan-japan.htmlhttp://dealbook.nytimes.com/2009/09/03/drug-maker-dainippon-to-buy-sepracor-for-26-billion/
http://www.nytimes.com/2005/05/08/fashion/weddings/08carb.html
http://www.nytimes.com/2002/11/20/classified/paid-notice-deaths-temple-maurice.html
http://www.nytimes.com/reuters/2014/07/08/sports/cycling/08reuters-cycling-road-tour-de-france-results.html
http://india.blogs.nytimes.com/2011/09/20/the-battle-over-generic-drugs-continues/
http://dealbook.nytimes.com/2009/02/27/astellas-commences-tender-offer-in-cv-bid/
http://query.nytimes.com/gst/abstract.html?res=9E01E7DC1131EE3BBC4152DFB4678382679EDE
http://query.nytimes.com/gst/abstract.html?res=9F07E4DF123DE731A25752C1A9679D946092D6CF
http://query.nytimes.com/gst/abstract.html?res=9C02EFD91638E33BBC4C52DFB0668388659EDE
http://www.nytimes.com/reuters/2013/06/11/business/11reuters-elan-royalty.htmlhttp://www.nytimes.com/2013/05/05/sports/cycling/mark-cavendish-leads-in-giro-ditalia.html
http://query.nytimes.com/gst/fullpage.html?res=9803E1DB123AF936A25751C0A9639C8B63
http://query.nytimes.com/gst/abstract.html?res=9D07E6DF143AE633A25757C1A9609C946596D6CF
http://www.nytimes.com/reuters/2014/04/22/business/22reuters-novartis-boltons.html
http://dealbook.nytimes.com/2008/04/28/japanese-drugmaker-buys-stake-in-comentis/
http://query.nytimes.com/gst/abstract.html?res=9804E4DB1031E73BBC4C51DFBE668383649EDE
http://query.nytimes.com/gst/abstract.html?res=9803E4DF1E3EE03BBC4D53DFBE668382659EDE
http://query.nytimes.com/gst/abstract.html?res=9A00E7DC173AE13ABC4951DFB4678383659EDE
http://www.nytimes.com/2002/11/02/business/generic-prilosec-to-be-marketed.html
http://www.nytimes.com/reuters/2014/09/19/sports/cycling/19reuters-cycling-world.htmlhttp://www.nytimes.com/2002/11/02/business/generic-prilosec-to-be-marketed.html
http://dealbook.nytimes.com/2008/06/11/japans-daiichi-coughs-up-46-billion-for-ranbaxy/
http://www.nytimes.com/2014/10/24/health/without-lucrative-market-potential-ebola-vaccine-was-shelved-for-years.html
http://www.nytimes.com/aponline/2013/03/04/business/ap-us-elan-tysabri-dividend.html
http://dealbook.nytimes.com/2010/04/26/charles-river-buys-chinese-drug-research-firm/
http://www.nytimes.com/reuters/2014/09/15/business/15reuters-markets-stocks.html
http://dealbook.nytimes.com/2013/07/29/perrigo-to-buy-irish-drug-maker-for-6-7-billion/
http://krugman.blogs.nytimes.com/2013/03/12/the-eurobeatings-will-continue/
http://query.nytimes.com/gst/fullpage.html?res=9900E5DC133CF935A25750C0A9639C8B63
http://www.nytimes.com/1992/12/28/business/the-media-business-advertising-addenda-accounts-132492.htmlhttp://query.nytimes.com/gst/abstract.html?res=9903E7D8123DE63ABC4C52DFB0668388669EDE
http://query.nytimes.com/gst/abstract.html?res=9E0DE5D81F3AEE32A25756C2A9679C946094D6CF
http://query.nytimes.com/gst/abstract.html?res=9B05E3DF123DE733A2575BC2A9639C946695D6CF
http://query.nytimes.com/gst/abstract.html?res=9F0DE7DB1F30EE3ABC4C53DFB5668389639EDE
http://query.nytimes.com/gst/abstract.html?res=9C05EFDD1638EF3BBC4C51DFB0668383649EDE
http://dealbook.nytimes.com/2008/05/16/as-private-equity-snaps-up-debt-others-stay-away/
http://query.nytimes.com/gst/fullpage.html?res=9F00E1D6133AF933A15753C1A9629C8B63
http://www.nytimes.com/2001/04/24/nyregion/metro-business-briefing-rohatyn-s-new-venture.html
http://query.nytimes.com/gst/abstract.html?res=950CE6DB113DEF34BC4B51DFBE668389669EDE
http://www.nytimes.com/2001/08/19/magazine/l-the-alchemy-of-oxycontin-695785.htmlhttp://query.nytimes.com/gst/abstract.html?res=9E01E5D61E31E135A25756C1A9679D946190D6CF
http://krugman.blogs.nytimes.com/2009/07/16/the-ama-as-good-guys/
http://www.nytimes.com/2000/10/04/business/world-business-briefing-europe-roche-rejects-genentech-sale.html
http://query.nytimes.com/gst/abstract.html?res=9905E1DE153FE03BBC4C53DFB166838D649EDE
http://query.nytimes.com/gst/abstract.html?res=9A03EFDD143CE53ABC4850DFB066838D629EDE
http://query.nytimes.com/gst/abstract.html?res=9E01EEDD173CE53ABC4E52DFB467838E629EDE
http://www.nytimes.com/aponline/2014/07/24/health/ap-eu-med-malaria-vaccine.html
http://www.nytimes.com/2014/06/12/business/international/ex-employee-of-novartiss-japan-unit-arrested.html
http://www.nytimes.com/2012/05/09/health/senate-panel-to-examine-narcotic-drug-makers-financial-ties.html
http://www.nytimes.com/2001/06/29/business/company-briefs-025887.htmlhttp://www.nytimes.com/2003/08/18/business/most-wanted-drilling-down-venture-capital-an-uptick-in-deals.html
http://www.nytimes.com/1997/11/09/style/weddings-kerry-nagle-douglas-pearl.html
http://query.nytimes.com/gst/abstract.html?res=9B0CE0D8173BE43BBC4D51DFB7678383649EDE
http://www.nytimes.com/reuters/2014/06/03/world/middleeast/03reuters-usa-drugs-lawsuit.html
http://www.nytimes.com/reuters/2014/09/03/sports/03reuters-cycling-spain.html
http://www.nytimes.com/aponline/2013/01/29/business/ap-us-wall-street-summary-box.html
http://www.nytimes.com/2006/04/05/business/05biomet.html
http://query.nytimes.com/gst/fullpage.html?res=9C06E6DB1F3CF931A15750C0A9639C8B63
http://www.nytimes.com/2001/02/28/us/national-news-briefs-officials-to-discuss-drug-blamed-for-deaths.html
http://dealbook.nytimes.com/2006/09/21/hospira-welcomes-mayne-into-the-fold/http://www.nytimes.com/2001/08/20/opinion/l-addicted-to-oxycontin-762512.html
http://query.nytimes.com/gst/abstract.html?res=9D02EFDF143BEF3BBC4153DFB1668382649EDE
http://www.nytimes.com/1993/03/29/style/weddings-holly-fidelman-and-leonard-weiss.html
http://query.nytimes.com/gst/abstract.html?res=9C03E3D6163BE33BBC4E52DFB7668389659EDE
http://dealbook.nytimes.com/2014/04/07/drug-sale-shows-risk-in-japans-m-a-adventures/
http://www.nytimes.com/2012/05/09/health/senate-panel-to-examine-narcotic-drug-makers-financial-ties.html
http://www.nytimes.com/2001/08/19/magazine/l-the-alchemy-of-oxycontin-695815.html
http://dealbook.nytimes.com/2006/09/25/triple-header-drugmaker-schwarz-agrees-to-be-bought/
http://dealbook.nytimes.com/2006/06/08/rival-bidders-could-crash-novartiss-neutec-party/
http://query.nytimes.com/gst/fullpage.html?res=9806E5DB153CF937A25750C0A9639C8B63http://www.nytimes.com/2004/08/15/business/l-government-s-role-in-fighting-obesity-636282.html
http://www.nytimes.com/2003/11/02/business/l-of-drug-research-and-company-mergers-953563.html
http://www.nytimes.com/1992/10/22/business/company-news-694092.html
http://query.nytimes.com/gst/abstract.html?res=9506E4D71431E73BBC4C51DFB4678388679EDE
http://query.nytimes.com/gst/abstract.html?res=9500E0D9133BE33BBC4F53DFB766838A659EDE
http://www.nytimes.com/1996/09/11/business/canadian-executive-named-to-head-astra-usa.html
http://query.nytimes.com/gst/abstract.html?res=9502EEDB1039E43BBC4153DFB3668388679EDE
http://query.nytimes.com/gst/abstract.html?res=9405EED71431E43ABC4F52DFB066838F649EDE
http://www.nytimes.com/aponline/2014/02/05/sports/ap-cyc-dubai-tour.html
http://www.nytimes.com/reuters/2013/06/10/business/10reuters-elan-royalty-court.htmlhttp://www.nytimes.com/reuters/2013/06/03/business/03reuters-elan-royalty-merger.html
http://www.nytimes.com/reuters/2012/10/15/business/15reuters-cinven.html
http://query.nytimes.com/gst/abstract.html?res=9E01EFDE1E31EF3BBC4B52DFBE668389679EDE
http://query.nytimes.com/gst/abstract.html?res=9C00E7DA1639E23BBC4E53DFB767838F659EDE
http://query.nytimes.com/gst/abstract.html?res=9E0DE7DC1E3AEE3ABC4A51DFB066838D639EDE
http://query.nytimes.com/gst/abstract.html?res=9E04E1DA1138E233A25757C2A9609C946495D6CF
http://query.nytimes.com/gst/abstract.html?res=9A04E3DD153FEF34BC4950DFB166838F669EDE
http://www.nytimes.com/reuters/2014/08/23/sports/cycling/23reuters-cycling-spain.html
http://www.nytimes.com/2009/09/04/business/global/04drug.html
http://krugman.blogs.nytimes.com/2011/12/19/irish-competitiveness-wonkish/http://www.nytimes.com/2010/04/06/business/06oxy.html
http://www.nytimes.com/reuters/2014/03/02/business/02reuters-novartis-chairman.html
http://krugman.blogs.nytimes.com/2012/11/14/the-austerity-bomb/
http://thecaucus.blogs.nytimes.com/2007/05/10/giulianis-tough-week/
http://dealbook.nytimes.com/2010/01/04/merz-to-buy-bioform-medical-for-253-million/
http://www.nytimes.com/reuters/2012/09/16/sports/cycling/16reuters-cycling-world-team-timetrial.html
http://www.nytimes.com/reuters/2014/08/12/business/12reuters-galenica.html
http://query.nytimes.com/gst/abstract.html?res=9901E4DE1131E23BBC4151DFB467838A649EDE
http://www.nytimes.com/aponline/2014/01/24/health/ap-eu-med-contraceptive-pill-review.html
http://www.nytimes.com/reuters/2014/08/13/business/13reuters-astrazeneca-gout.htmlhttp://www.nytimes.com/reuters/2014/06/18/sports/cycling/18reuters-cycling-wiggins.html
http://www.nytimes.com/aponline/2014/08/30/us/ap-us-minnesota-senate-inversion.html
http://www.nytimes.com/aponline/2013/06/17/business/ap-us-elan-royalty-pharma.html
http://www.nytimes.com/reuters/2013/07/12/business/12reuters-elan-bids.html
http://www.nytimes.com/aponline/2014/08/29/us/politics/ap-us-minnesota-senate-inversion.html
http://www.nytimes.com/aponline/2014/09/16/us/politics/ap-us-prescription-painkillers-cities.html
http://www.nytimes.com/reuters/2014/09/04/sports/cycling/04reuters-cycling-britain-cavendish.html
http://www.nytimes.com/2007/04/08/business/yourmoney/08frame.html
http://www.nytimes.com/aponline/2014/06/03/us/ap-us-painkiller-makers-lawsuit-chicago.html
http://www.nytimes.com/2014/09/30/upshot/what-were-learning-about-drug-company-payments-to-doctors.htmlhttp://www.nytimes.com/2014/09/30/business/patents-put-overseas-can-pare-tax-bills.html
http://op-talk.blogs.nytimes.com/2014/10/02/do-you-have-time-to-read-this-story/
http://www.nytimes.com/2012/09/21/movies/doctored-a-defense-of-chiropractic-aid.html
http://krugman.blogs.nytimes.com/2011/12/21/the-imf-on-ireland/
http://query.nytimes.com/gst/abstract.html?res=9800E5D7163BE13ABC4F53DFB066838E679EDE
http://www.nytimes.com/1964/10/03/judge-to-sentence-chemist-on-nov-6-in-drugdata-theft.html
http://query.nytimes.com/gst/abstract.html?res=9D06E6DA1E31E23BBC4953DFB667838D649EDE
http://query.nytimes.com/gst/abstract.html?res=9E0DEEDE153CEE3BBC4852DFB3668388659EDE
http://query.nytimes.com/gst/abstract.html?res=9906E0D6133DE533A25755C2A96E9C946896D6CF
http://www.nytimes.com/reuters/2013/04/22/business/22reuters-elan-royalty.htmlhttp://www.nytimes.com/2014/05/13/opinion/nocera-science-vs-taxes.html
http://www.nytimes.com/2012/03/27/science/profiting-from-medicine.html
http://www.nytimes.com/2011/07/03/fashion/weddings/lindsay-ross-garrett-ricciardi-weddings.html
http://www.nytimes.com/2002/03/05/business/company-briefs-919470.html
http://query.nytimes.com/gst/abstract.html?res=9E00EED9143AE033A05750C1A9649D946792D6CF
http://www.nytimes.com/reuters/2013/06/04/business/04reuters-elan-royalty.html
http://www.nytimes.com/reuters/2014/09/12/business/12reuters-alibaba-group-ipo-performance-analysis.html
http://www.nytimes.com/reuters/2013/04/22/business/22reuters-informa-results.html
http://www.nytimes.com/2006/06/04/fashion/weddings/04mahm.html
http://query.nytimes.com/gst/fullpage.html?res=9A05E0D81E31F93AA25750C0A9609C8B63http://www.nytimes.com/1994/11/22/science/a-drug-cocktail-cuts-hiv-levels.html
http://query.nytimes.com/gst/abstract.html?res=9804E6DD1430EF3BBC4151DFB2668388679EDE
http://www.nytimes.com/reuters/2012/09/01/business/01reuters-bayer-greece-exit.html
http://bucks.blogs.nytimes.com/2011/12/27/tuesday-reading-how-government-austerity-affects-health-care/
http://query.nytimes.com/gst/fullpage.html?res=9401E1DD143AF937A15755C0A96F9C8B63
http://www.nytimes.com/2006/06/18/fashion/weddings/18doan.html
http://www.nytimes.com/reuters/2014/07/07/sports/cycling/07reuters-cycling-tour-cavendish.html
http://www.nytimes.com/reuters/2013/08/22/sports/cycling/22reuters-cycling-boonen.html
http://www.legacy.com/Link.asp?I=LS000166265017
http://india.blogs.nytimes.com/2012/03/13/india-orders-bayer-to-license-a-patented-drug/http://query.nytimes.com/gst/abstract.html?res=9C0CE4D91530EE32A25750C1A9639C94689ED7CF
http://www.nytimes.com/reuters/2012/09/01/business/01reuters-bayer-greece-exit.html
http://bucks.blogs.nytimes.com/2011/12/27/tuesday-reading-how-government-austerity-affects-health-care/
http://query.nytimes.com/gst/fullpage.html?res=9401E1DD143AF937A15755C0A96F9C8B63
http://www.nytimes.com/2006/06/18/fashion/weddings/18doan.html
http://www.nytimes.com/reuters/2014/07/07/sports/cycling/07reuters-cycling-tour-cavendish.html
http://www.nytimes.com/reuters/2013/08/22/sports/cycling/22reuters-cycling-boonen.html
http://www.legacy.com/Link.asp?I=LS000166265017
http://india.blogs.nytimes.com/2012/03/13/india-orders-bayer-to-license-a-patented-drug/
http://www.nytimes.com/2008/07/06/fashion/weddings/06SHU.htmlhttp://www.nytimes.com/2006/06/04/fashion/weddings/04mahm.html
http://query.nytimes.com/gst/fullpage.html?res=9A05E0D81E31F93AA25750C0A9609C8B63
http://www.nytimes.com/1992/04/14/business/finance-briefs-088192.html
http://query.nytimes.com/gst/abstract.html?res=9B0CE3DA133DE13ABC4B51DFBF668388669EDE
http://www.nytimes.com/reuters/2014/08/14/technology/14reuters-mobilephone-health.html
http://www.nytimes.com/reuters/2013/07/10/sports/cycling/10reuters-cycling-tour-cavendish.html
http://www.nytimes.com/reuters/2012/08/22/business/22reuters-india-novartis.html
http://dealbook.nytimes.com/2008/06/19/bentley-forges-ahead-with-cpex-spin-off/
http://dealbook.nytimes.com/2008/03/31/lehman-to-sue-japans-marubeni-for-fraud-report-says/
http://www.nytimes.com/1998/07/12/style/weddings-ms-fried-mr-ehrlich.htmlhttp://www.nytimes.com/reuters/2014/09/11/world/europe/11reuters-health-ebola-neglected-analysis.html
http://www.nytimes.com/aponline/2013/04/16/us/politics/ap-us-oxycontin-generic-versions.html
http://query.nytimes.com/gst/fullpage.html?res=9407EFDD143AF936A3575BC0A9659D8B63
http://www.nytimes.com/2012/04/22/fashion/weddings/yiyang-wu-benjamin-cheng-weddings.html
http://dealbook.nytimes.com/2007/08/22/pfizer-should-buy-wyeth-to-cure-what-ails-it-analyst-says/
http://www.nytimes.com/2004/02/22/weekinreview/l-letters-public-editor-other-voices-some-dissenting-views-readers-stubbing-toe-502197.html
http://www.nytimes.com/2004/01/31/us/rep-tauzin-leans-toward-retirement.html
http://query.nytimes.com/gst/abstract.html?res=9A02EED61E3FE63ABC4A52DFBF66838A669EDE
http://query.nytimes.com/gst/abstract.html?res=9402E2DA163FE53BBC4952DFB066838C679EDE
http://www.nytimes.com/reuters/2014/07/09/business/09reuters-credit-suisse-healthcare.htmlhttp://query.nytimes.com/gst/abstract.html?res=9A02EED61E3FE63ABC4A52DFBF66838A669EDE
http://query.nytimes.com/gst/abstract.html?res=9402E2DA163FE53BBC4952DFB066838C679EDE
http://krugman.blogs.nytimes.com/2013/05/17/that-hideous-strength/
http://www.nytimes.com/2011/08/20/business/lawyer-sentenced-in-insider-trading-case.html
http://www.nytimes.com/2011/07/31/fashion/weddings/anika-leerssen-chad-marriott-weddings.html
http://www.nytimes.com/2010/03/02/business/02drug.html
http://query.nytimes.com/gst/abstract.html?res=9806EFD7133EEF34BC4A52DFB566838D669EDE
http://dealbook.nytimes.com/2014/11/07/morning-agenda-bank-of-americas-legal-hit/
http://www.nytimes.com/reuters/2014/09/11/business/11reuters-alibaba-group-ipo-performance-analysis.html
http://www.nytimes.com/aponline/2013/06/04/business/ap-us-elan-royalty-pharma-restraining-order.htmlhttp://www.nytimes.com/2011/07/03/fashion/weddings/lindsay-ross-garrett-ricciardi-weddings.html
http://www.nytimes.com/1999/04/26/business/dividend-meetings-396400.html
http://query.nytimes.com/gst/abstract.html?res=9D0DEFDA153FE334BC4950DFB166838D669EDE
http://query.nytimes.com/gst/abstract.html?res=9506E5DF153EE23ABC4E51DFB6678382629EDE
http://www.nytimes.com/reuters/2014/09/11/business/11reuters-alibaba-group-ipo-performance-analysis.html
http://dealbook.nytimes.com/2014/11/07/morning-agenda-bank-of-americas-legal-hit/
http://www.nytimes.com/aponline/2013/06/04/business/ap-us-elan-royalty-pharma-restraining-order.html
http://query.nytimes.com/gst/abstract.html?res=9C01E0DD153EE334BC4151DFB667838D669EDE
http://dealbook.nytimes.com/2014/02/24/cinven-to-buy-clinical-research-firm/
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-novartis-tokyo-raid.htmlhttp://dealbook.nytimes.com/2014/02/24/cinven-to-buy-clinical-research-firm/
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-novartis-tokyo-raid.html
http://www.nytimes.com/reuters/2013/09/21/sports/cycling/21reuters-cycling-britain.html
http://www.nytimes.com/2012/04/22/fashion/weddings/yiyang-wu-benjamin-cheng-weddings.html
http://www.nytimes.com/2011/03/01/business/global/01drug.html
http://www.nytimes.com/2006/05/14/fashion/weddings/14RIPP.html
http://query.nytimes.com/gst/abstract.html?res=9B07E5DE1631E73BBC4B51DFB2668388679EDE
http://query.nytimes.com/gst/abstract.html?res=9A00E5D91639E33BBC4E52DFB566838C649EDE
http://query.nytimes.com/gst/abstract.html?res=9904E4DF153AE53BBC4F51DFB266838F649EDE
http://query.nytimes.com/gst/abstract.html?res=9907E2DF143BE03ABC4A53DFB767838A649EDEhttp://www.nytimes.com/aponline/2014/07/24/health/ap-eu-med-contraceptives-review.html
http://www.nytimes.com/aponline/2014/03/03/us/ap-us-forbes-billionaires-glance.html
http://www.legacy.com/Link.asp?I=LS000163321031
http://www.nytimes.com/reuters/2012/12/12/business/12reuters-markets-stocks-ftse-rejigurgent.html
http://krugman.blogs.nytimes.com/2011/10/25/irish-reality-check/
http://www.nytimes.com/2011/03/16/us/16lethal.html
http://query.nytimes.com/gst/abstract.html?res=9907EEDF1131E23BBC4051DFB467838A649EDE
http://www.nytimes.com/2011/01/28/opinion/28fri3.html
http://www.nytimes.com/2011/07/31/fashion/weddings/anika-leerssen-chad-marriott-weddings.html
http://query.nytimes.com/gst/fullpage.html?res=9801E1DA1F31F932A25754C0A9669D8B63http://dealbook.nytimes.com/2010/03/02/will-rival-bidders-join-the-fray-for-osi/
http://www.legacy.com/Link.asp?I=LS000128846685
http://query.nytimes.com/gst/abstract.html?res=9D0CE5DD1E3EE63BBC4B51DFB3668383649EDE
http://www.nytimes.com/reuters/2014/05/27/sports/cycling/27reuters-cycling-holm.html
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-tokyo-prosecutors-raid-novartis-japan-unit-i.html
http://www.nytimes.com/reuters/2013/02/26/business/26reuters-nestle.html
http://www.nytimes.com/2011/03/16/us/16lethal.html
http://www.nytimes.com/2005/11/10/business/10drugs.html
http://www.nytimes.com/reuters/2014/01/07/business/07reuters-forest-aptalis.html
http://www.nytimes.com/reuters/2014/04/09/business/09reuters-ranbaxy-lab-regulator.htmlhttp://www.nytimes.com/2011/01/28/opinion/28fri3.html
http://query.nytimes.com/gst/abstract.html?res=9405E1DF1230E63ABC4E53DFB3668388669EDE
http://www.nytimes.com/2007/06/11/business/11carr.html
http://www.nytimes.com/reuters/2012/08/29/us/29reuters-heart-pharmaceuticals.html
http://www.nytimes.com/1997/05/04/nyregion/four-companies-get-governor-s-citation.html
http://www.nytimes.com/2001/03/11/business/market-insight-drug-makers-may-have-to-give-to-get.html
http://www.nytimes.com/2008/03/25/books/25kaku.html
http://www.nytimes.com/reuters/2013/06/18/business/18reuters-elan-royalty.html
http://www.nytimes.com/reuters/2013/04/15/business/15reuters-royaltypharma-elan.html
http://www.nytimes.com/reuters/2013/07/11/sports/cycling/11reuters-cycling-tour.htmlhttp://www.nytimes.com/1989/01/17/world/letter-indicates-more-links-between-gas-plant-builders.html
http://www.nytimes.com/1999/06/19/business/business-digest-237469.html
http://www.nytimes.com/aponline/2013/01/10/us/politics/ap-us-sleeping-pills-fda-safety.html
http://www.nytimes.com/1995/07/11/business/sandoz-buying-genetic-therapy-for-295-million.html
http://www.nytimes.com/reuters/2013/07/18/business/18reuters-gsk-china-ucb.html
http://www.nytimes.com/2003/07/30/us/drug-lobby-pushed-letter-by-senators-on-medicare.html
http://www.nytimes.com/reuters/2014/05/01/business/01reuters-shire.html
http://www.nytimes.com/reuters/2013/07/11/sports/cycling/11reuters-cyycling-tour-winner.html
http://www.nytimes.com/1996/02/04/us/judge-orders-f-lee-baily-to-return-3-million-or-go-to-prison.html
http://www.nytimes.com/2013/04/04/business/media/an-ms-drug-takes-a-feisty-approach-aimed-at-younger-patients.htmlhttp://www.nytimes.com/reuters/2013/07/02/sports/cycling/02reuters-cycling-tour.html
http://www.nytimes.com/reuters/2013/07/02/sports/cycling/02reuters-cycling-tour-winner.html
http://www.nytimes.com/reuters/2012/01/13/business/business-us-novartis.html
http://www.nytimes.com/reuters/2014/01/26/business/26reuters-pharmaceutical-deals-analysis.html
http://query.nytimes.com/gst/abstract.html?res=9F00EFD9113FE034BC4E52DFB766838B669EDE
http://www.nytimes.com/reuters/2014/04/04/business/04reuters-meda-mylan.html
http://www.nytimes.com/reuters/2013/07/19/business/19reuters-gsk-china-ucb.html
http://www.nytimes.com/reuters/2013/05/13/business/13reuters-elan-theravance.html
http://www.nytimes.com/reuters/2013/06/21/business/21reuters-vivus-proxy.html
http://query.nytimes.com/gst/abstract.html?res=9B0DE7D7113DE63ABC4153DFBF668388669EDEhttp://www.nytimes.com/2009/02/04/business/04drug.html
http://www.nytimes.com/reuters/2013/04/12/business/12reuters-elan-royalty.html
http://www.nytimes.com/2004/07/06/us/pill-thefts-alter-the-look-of-rural-drugstores.html
http://www.nytimes.com/reuters/2014/08/10/sports/cycling/10reuters-cycling-london.html
http://www.nytimes.com/aponline/2013/12/11/us/politics/ap-us-generic-cymbalta.html
http://www.nytimes.com/reuters/2013/07/24/business/24reuters-elan-bids.html
http://www.nytimes.com/2012/03/27/science/profiting-from-medicine.html
http://dealbook.nytimes.com/2011/05/24/nestle-to-buy-diagnostics-firm/
http://prescriptions.blogs.nytimes.com/2010/10/27/recommended-reading-bad-science/
http://dealbook.nytimes.com/2009/01/27/astellas-makes-hostile-bid-for-cv-therapeutics/http://opinionator.blogs.nytimes.com/2008/03/03/immune-to-the-facts/
http://www.nytimes.com/1989/09/19/business/briefs-749589.html
http://query.nytimes.com/gst/abstract.html?res=9407E2DB1038E63ABC4850DFB5668389679EDE
http://query.nytimes.com/gst/abstract.html?res=9800E1D71539E133A25757C2A9649D946095D6CF
http://dealbook.nytimes.com/2008/10/10/doubts-grow-over-lillys-imclone-deal/
http://query.nytimes.com/gst/abstract.html?res=9E06E4DD173BE436A75751C2A9669D946190D6CF
http://query.nytimes.com/gst/abstract.html?res=9806EFD91F3CE03ABC4B52DFBE668383659EDE
http://query.nytimes.com/gst/abstract.html?res=9D01EEDC153BEE3BBC4D51DFB366838E659EDE
http://query.nytimes.com/gst/abstract.html?res=9D02E0DA173FE33BBC4E53DFB4678389659EDE
http://www.nytimes.com/reuters/2014/04/07/world/europe/07reuters-usa-court-ip.htmlhttp://query.nytimes.com/gst/fullpage.html?res=9C03E0DD133BF93AA25756C0A9679D8B63
http://dealbook.nytimes.com/2010/03/02/pfizer-said-to-set-sights-on-german-drug-maker/
http://www.nytimes.com/1999/05/03/business/james-whittam-49-president-and-chief-of-shaklee-companies.html
http://www.nytimes.com/1992/04/07/health/the-doctor-s-world-cancer-drug-s-good-side-effects.html
http://query.nytimes.com/gst/abstract.html?res=9C00EEDD1631EE34BC4052DFBE66838B669EDE
http://query.nytimes.com/gst/abstract.html?res=9D05E5DA1F3AE53ABC4052DFB4668388649EDE
http://query.nytimes.com/gst/abstract.html?res=9804E2D8173DE533A25756C1A9619C94639FD7CF
http://www.nytimes.com/reuters/2014/08/05/business/05reuters-kremersurban-sale.html
http://www.nytimes.com/reuters/2014/05/06/business/06reuters-astrazeneca-pfizer-epanova.html
http://www.nytimes.com/reuters/2013/04/02/business/02reuters-elan.htmlhttp://www.nytimes.com/reuters/2012/06/26/technology/26reuters-pharma-games.html
http://query.nytimes.com/gst/fullpage.html?res=9F00E0DD173CF930A15751C0A9679D8B63
http://www.nytimes.com/2009/11/21/opinion/l21drug.html
http://economix.blogs.nytimes.com/2009/11/18/health-care-reform-and-mckinseys-client-x/
http://schott.blogs.nytimes.com/2009/09/15/beagle-smoking-issues/
http://thecaucus.blogs.nytimes.com/2007/12/28/giuliani-defends-work-with-drug-clients/
http://query.nytimes.com/gst/fullpage.html?res=9F05E3DC1131F932A35752C1A9619C8B63
http://www.nytimes.com/reuters/2014/08/06/sports/cycling/06reuters-cycling-cavendish.html
http://www.nytimes.com/reuters/2014/04/12/sports/cycling/12reuters-cycling-basque.html
http://www.nytimes.com/2013/05/11/business/endo-loses-bid-to-block-sales-of-generic-painkiller.htmlhttp://www.nytimes.com/aponline/2013/06/07/business/ap-us-wall-street-stocks.html
http://dealbook.nytimes.com/2009/03/13/analysts-mixed-on-sweetened-astellas-bid-for-cv-therapeutics/
http://www.nytimes.com/2009/03/13/business/13biotech.html
http://dealbook.nytimes.com/2009/02/19/glaxo-leads-23-million-round-for-genocea/
http://www.nytimes.com/2003/11/25/science/the-delicate-balance-of-pain-and-addiction.html
http://www.nytimes.com/reuters/2014/08/05/business/05reuters-kremersurban-sale.html
http://www.nytimes.com/reuters/2014/05/06/business/06reuters-astrazeneca-pfizer-epanova.html
http://www.nytimes.com/reuters/2013/04/02/business/02reuters-elan.html
http://www.nytimes.com/reuters/2012/06/26/technology/26reuters-pharma-games.html
http://query.nytimes.com/gst/fullpage.html?res=9F00E0DD173CF930A15751C0A9679D8B63http://www.nytimes.com/2009/11/21/opinion/l21drug.html
http://economix.blogs.nytimes.com/2009/11/18/health-care-reform-and-mckinseys-client-x/
http://schott.blogs.nytimes.com/2009/09/15/beagle-smoking-issues/
http://thecaucus.blogs.nytimes.com/2007/12/28/giuliani-defends-work-with-drug-clients/
http://query.nytimes.com/gst/fullpage.html?res=9F05E3DC1131F932A35752C1A9619C8B63
http://www.nytimes.com/reuters/2014/08/06/sports/cycling/06reuters-cycling-cavendish.html
http://www.nytimes.com/reuters/2014/04/12/sports/cycling/12reuters-cycling-basque.html
http://www.nytimes.com/2013/05/11/business/endo-loses-bid-to-block-sales-of-generic-painkiller.html
http://www.nytimes.com/reuters/2013/04/03/business/03reuters-astrazeneca.html
http://www.nytimes.com/2012/03/20/business/ex-adviser-pleads-guilty-in-insider-trading-case.htmlhttp://www.nytimes.com/2001/11/02/us/a-nation-challenged-the-antibiotics-warning-raised-against-a-drug.html
http://query.nytimes.com/gst/abstract.html?res=9D03E7DA163DE03ABC4D51DFB066838D669EDE
http://query.nytimes.com/gst/abstract.html?res=9E0DE5DD1431E233A2575BC2A9659C946096D6CF
http://www.nytimes.com/aponline/2014/05/15/us/politics/ap-us-lunesta-fda-action.html
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-novartis-japan-raid.html
http://6thfloor.blogs.nytimes.com/2011/09/19/three-favorite-novels-by-le-carre/
http://www.nytimes.com/2010/08/31/health/research/31muscleside.html
http://dealbook.nytimes.com/2010/02/28/germanys-merck-to-buy-millipore-for-7-2-billion/
http://www.nytimes.com/ref/health/healthguide/esn-gerd-trials.html
/data/daily/2007/09/20/302457.sgmlhttp://www.nytimes.com/aponline/2014/08/06/business/ap-us-financial-markets-stocks.html
http://www.nytimes.com/aponline/2014/07/23/business/ap-us-new-painkiller-fda.html
http://www.nytimes.com/reuters/2014/06/20/business/20reuters-markets-britain-stocks.html
http://krugman.blogs.nytimes.com/2011/12/06/irish-pfizer-smiling/
http://query.nytimes.com/gst/fullpage.html?res=9505EFDF113AF930A1575BC0A9679D8B63
http://dealbook.nytimes.com/2009/06/17/uk-accuses-lawyers-at-us-firm-of-insider-trades/
http://query.nytimes.com/gst/fullpage.html?res=9405EFDD1631F935A25754C0A9619C8B63
http://query.nytimes.com/gst/abstract.html?res=9D07E5DB1439E334BC4851DFB766838C669EDE
http://query.nytimes.com/gst/abstract.html?res=9501EEDA1F30E73BBC4A51DFB6678382679EDE
http://query.nytimes.com/gst/abstract.html?res=9F0CE2DA143EEF3BBC4052DFB466838B649EDEhttp://www.nytimes.com/aponline/2014/08/06/business/ap-us-financial-markets-stocks.html
http://www.nytimes.com/aponline/2014/07/23/business/ap-us-new-painkiller-fda.html
http://www.nytimes.com/reuters/2014/06/20/business/20reuters-markets-britain-stocks.html
http://krugman.blogs.nytimes.com/2011/12/06/irish-pfizer-smiling/
http://query.nytimes.com/gst/fullpage.html?res=9505EFDF113AF930A1575BC0A9679D8B63
http://dealbook.nytimes.com/2009/06/17/uk-accuses-lawyers-at-us-firm-of-insider-trades/
http://query.nytimes.com/gst/fullpage.html?res=9405EFDD1631F935A25754C0A9619C8B63
http://query.nytimes.com/gst/abstract.html?res=9D07E5DB1439E334BC4851DFB766838C669EDE
http://query.nytimes.com/gst/abstract.html?res=9501EEDA1F30E73BBC4A51DFB6678382679EDE
http://query.nytimes.com/gst/abstract.html?res=9F0CE2DA143EEF3BBC4052DFB466838B649EDEhttp://query.nytimes.com/gst/abstract.html?res=9A0CEFD81F3AE53BBC4953DFB5668383649EDE
http://www.nytimes.com/2014/06/24/sports/cycling/rui-costa-wins-3rd-straight-tour-de-suisse.html
http://www.nytimes.com/reuters/2014/02/19/business/19reuters-tokyo-novartis.html
http://www.nytimes.com/reuters/2013/06/14/business/14reuters-elan-royalty.html
http://www.nytimes.com/2010/02/14/books/review/EdChoice-t.html
http://www.nytimes.com/2004/12/23/business/23drug.html
http://www.nytimes.com/1996/03/12/business/athena-wins-us-approval-of-a-new-drug.html
http://query.nytimes.com/gst/abstract.html?res=9D01E7D8153AE23BBC4C51DFB1668389649EDE
http://www.nytimes.com/reuters/2013/06/13/business/13reuters-elan-royalty.html
http://www.nytimes.com/aponline/2013/03/25/us/ap-10-things-to-know-today.htmlhttp://www.nytimes.com/2011/06/16/health/16oxy.html
/data/daily/2007/10/19/683060.sgml
http://www.nytimes.com/2004/12/12/magazine/12MAKING.html
http://www.nytimes.com/2002/07/17/business/orthopedics-maker-ousts-chief-in-a-dispute-over-management.html
http://query.nytimes.com/gst/abstract.html?res=990DE0DC1E39E63BBC4952DFB767838E669EDE
http://query.nytimes.com/gst/abstract.html?res=9A02EEDC1F3FE432A25757C0A9649D946094D6CF
http://www.nytimes.com/reuters/2013/05/29/business/29reuters-amgen-astellas.html
http://www.nytimes.com/aponline/2013/04/08/business/ap-us-wall-street-stocks.html
http://www.nytimes.com/aponline/2012/12/21/us/ap-10-things-to-know-friday.html
http://dealbook.nytimes.com/2011/08/19/lawyer-tied-to-galleon-case-gets-3-years-in-prison/http://www.nytimes.com/2010/09/23/business/23novartis.html
http://www.nytimes.com/2001/09/07/business/the-media-business-advertising-addenda-accounts-070424.html
http://query.nytimes.com/gst/abstract.html?res=9E00EFDC173BE436A7575BC0A9649C946790D6CF
http://query.nytimes.com/gst/abstract.html?res=940CE5D81639EF3BBC4953DFB1668382679EDE
http://query.nytimes.com/gst/abstract.html?res=9C04EEDF133DE33BBC4A51DFB466838A659EDE
http://query.nytimes.com/gst/abstract.html?res=9E04E1DF1239E632A25752C2A96E9C946695D6CF
http://query.nytimes.com/gst/abstract.html?res=950CEEDC1430E132A25757C0A9609C94689ED7CF
http://www.legacy.com/Link.asp?I=LS000153259749
http://dealbook.nytimes.com/2011/07/11/lonza-to-buy-arch-chemicals-for-1-2-billion/
http://www.nytimes.com/2009/03/13/business/13biotech.htmlhttp://www.nytimes.com/2008/10/09/arts/television/09test.html
http://www.nytimes.com/1996/06/13/us/new-treatment-helps-fight-crohn-s-disease.html
http://www.nytimes.com/reuters/2013/01/23/business/23reuters-novartis.html
http://query.nytimes.com/gst/abstract.html?res=9C03E6DE143CE43BBC4E53DFB667838D679EDE
http://dealbook.nytimes.com/2014/04/28/forest-labs-to-acquire-furiex-pharmaceuticals/
http://www.nytimes.com/reuters/2014/04/18/world/europe/18reuters-usa-court-teva-pharm-ind.html
http://www.nytimes.com/reuters/2013/09/22/sports/cycling/22reuters-cycling-world-teamtrial.html
http://krugman.blogs.nytimes.com/2013/04/13/dnwr-in-the-ea/
http://dealbook.nytimes.com/2012/08/08/kindler-former-pfizer-chief-joins-lux-capital/
http://www.nytimes.com/2011/08/20/business/lawyer-sentenced-in-insider-trading-case.htmlhttp://dealbook.nytimes.com/2009/05/06/safe-and-sound-at-13-million-a-year/
http://www.nytimes.com/2007/12/19/business/19lilly.html
http://www.nytimes.com/2002/03/03/books/books-in-brief-fiction-758078.html
http://www.nytimes.com/1995/12/12/business/the-media-business-advertising-addenda-accounts-005746.html
http://query.nytimes.com/gst/abstract.html?res=9C01E1DC1F3AEF34BC4951DFBF66838E649EDE
http://query.nytimes.com/gst/abstract.html?res=9A04E2D7103DE03ABC4F53DFBE668382659EDE
http://query.nytimes.com/gst/abstract.html?res=9B04E4DF123DE13BBC4E53DFB266838F659EDE
http://www.nytimes.com/2006/07/01/business/01nocera.html
http://www.nytimes.com/reuters/2014/08/25/business/25reuters-intermune-roche.html
http://www.nytimes.com/reuters/2014/08/24/business/24reuters-intermune-roche.htmlhttp://www.nytimes.com/reuters/2014/05/14/business/14reuters-astrazeneca-pfizer-jj.html
http://www.nytimes.com/2009/01/09/business/09views.html
http://www.nytimes.com/2012/03/13/business/global/india-overrules-bayer-allowing-generic-drug.html
http://www.nytimes.com/aponline/2012/01/12/us/AP-US-Powerful-Painkiller.html
http://dealbook.nytimes.com/2014/08/24/roche-to-buy-drug-maker-intermune-for-8-3-billion/
http://www.nytimes.com/aponline/2013/07/09/sports/ap-cyc-tour-de-france-5-things-to-know.html
http://www.nytimes.com/1996/03/19/business/irish-drug-concern-to-buy-athena-for-625-million.html
http://query.nytimes.com/gst/abstract.html?res=9807E6DA153AEE3ABC4051DFB366838A629EDE
http://www.nytimes.com/reuters/2014/05/14/business/14reuters-astrazeneca-pfizer-j-j.html
http://www.nytimes.com/reuters/2012/11/13/world/americas/13reuters-pharmaceuticals-fake-who.htmlhttp://www.nytimes.com/2004/02/07/us/washington-talk-lawmaker-s-plans-to-lobby-raises-issue-of-crossing-line.html
http://www.nytimes.com/aponline/2014/04/21/us/ap-us-allergan-valeant.html
http://www.nytimes.com/reuters/2013/05/23/business/23reuters-elan-royalty.html
http://www.nytimes.com/2007/01/11/nyregion/11imposter.html
http://query.nytimes.com/gst/abstract.html?res=9F00E4DA163DE03ABC4D51DFB066838D669EDE
http://query.nytimes.com/gst/abstract.html?res=9A01E4DB163CE731A25757C2A9669D946791D6CF
http://query.nytimes.com/gst/abstract.html?res=990DE6D9113CE63BBC4952DFB3668382649EDE
http://www.nytimes.com/2005/05/06/opinion/06krugman.html
http://www.nytimes.com/2004/10/10/business/yourmoney/10drug.html
http://www.nytimes.com/1982/01/18/business/executive-changes-176281.htmlhttp://query.nytimes.com/gst/abstract.html?res=9C02E4DF1038EF34BC4951DFB667838A669EDE
http://www.nytimes.com/reuters/2013/08/14/business/14reuters-novartis-review.html
http://query.nytimes.com/gst/fullpage.html?res=9E03E7DE173AF933A15754C0A9629D8B63
http://www.nytimes.com/reuters/2013/09/11/business/11reuters-roche-interview.html
http://www.nytimes.com/reuters/2013/06/12/business/12reuters-elan-royalty-appeal.html
http://green.blogs.nytimes.com/2010/03/09/scientists-develop-highly-recyclable-plastic/
http://www.nytimes.com/2009/12/11/business/11insider.html
http://www.nytimes.com/2009/10/07/business/global/07eurodrugs.html
http://query.nytimes.com/gst/abstract.html?res=9D07E6DF1E3AE034BC4F53DFBE66838E669EDE
http://query.nytimes.com/gst/abstract.html?res=9A02E7DC143AE53ABC4D51DFB066838F659EDEhttp://query.nytimes.com/gst/abstract.html?res=9A00E5DF1431E73ABC4E52DFB0668382639EDE
http://query.nytimes.com/gst/fullpage.html?res=9E03E7DE173AF933A15754C0A9629D8B63
http://www.nytimes.com/reuters/2013/09/11/business/11reuters-roche-interview.html
http://www.nytimes.com/reuters/2013/06/12/business/12reuters-elan-royalty-appeal.html
http://green.blogs.nytimes.com/2010/03/09/scientists-develop-highly-recyclable-plastic/
http://www.nytimes.com/2009/12/11/business/11insider.html
http://www.nytimes.com/2009/10/07/business/global/07eurodrugs.html
http://query.nytimes.com/gst/abstract.html?res=9D07E6DF1E3AE034BC4F53DFBE66838E669EDE
http://query.nytimes.com/gst/abstract.html?res=9A02E7DC143AE53ABC4D51DFB066838F659EDE
http://dealbook.nytimes.com/2013/12/31/the-risks-of-investing-in-animal-medicine/http://query.nytimes.com/gst/abstract.html?res=9404E4DE1E3AE23BBC4B51DFB4678389649EDE
http://query.nytimes.com/gst/abstract.html?res=9F0CE7DE1E3FE233A25753C1A9619C946796D6CF
http://query.nytimes.com/gst/abstract.html?res=9B0CE1DC1331E733A25752C0A9679C946697D6CF
http://dealbook.nytimes.com/2013/12/31/the-risks-of-investing-in-animal-medicine/
http://www.nytimes.com/2011/05/16/business/16insider.html
http://www.nytimes.com/2009/04/30/business/30wyeth.html
http://www.nytimes.com/2006/01/22/business/yourmoney/22mark.html
http://query.nytimes.com/gst/abstract.html?res=9E02E2DE103FE136A05754C2A9629C946490D6CF
http://www.nytimes.com/2012/07/03/sports/cycling/mark-cavendish-wins-tour-sprint-even-without-teammates-help.html
http://www.nytimes.com/2002/05/19/realestate/in-the-region-westchester-builders-are-moving-to-fill-demand-for-lab-space.htmlhttp://www.nytimes.com/reuters/2013/04/24/technology/24reuters-thermofisher-results.html
http://query.nytimes.com/gst/fullpage.html?res=9D06E0DC1E3CF937A25752C1A9629C8B63
http://www.nytimes.com/1999/12/23/us/drug-may-replace-steroids-for-asthma-patients.html
http://query.nytimes.com/gst/abstract.html?res=9E07E0D81230E43BBC4F53DFB767838D679EDE
http://query.nytimes.com/gst/abstract.html?res=9404E4DE1E3AE23BBC4B51DFB4678389649EDE
http://query.nytimes.com/gst/abstract.html?res=9F0CE7DE1E3FE233A25753C1A9619C946796D6CF
http://query.nytimes.com/gst/abstract.html?res=9B0CE1DC1331E733A25752C0A9679C946697D6CF
http://www.nytimes.com/2012/07/03/sports/cycling/mark-cavendish-wins-tour-sprint-even-without-teammates-help.html
http://www.nytimes.com/2002/05/19/realestate/in-the-region-westchester-builders-are-moving-to-fill-demand-for-lab-space.html
http://www.nytimes.com/reuters/2014/07/30/technology/30reuters-healthcare-tech.htmlhttp://www.nytimes.com/reuters/2013/05/30/business/30reuters-elan.html
http://www.nytimes.com/aponline/2013/05/13/business/ap-us-elan-theravance-royalty-agreement.html
http://www.nytimes.com/2010/09/21/health/21bbox.html
http://www.nytimes.com/2009/04/30/business/30wyeth.html
http://query.nytimes.com/gst/abstract.html?res=9E00E0DA1338E732A2575AC0A9639C94619FD6CF
http://query.nytimes.com/gst/abstract.html?res=940DE2DF143AEF3BBC4C52DFB4668383679EDE
http://query.nytimes.com/gst/abstract.html?res=9E02EEDB1639E63BBC4D51DFB266838D679EDE
http://query.nytimes.com/gst/abstract.html?res=9D05E0D91230EF3BBC4A51DFB1668388679EDE
http://query.nytimes.com/gst/abstract.html?res=9F01E7D81F3FE43BBC4D53DFB0668383649EDE
http://query.nytimes.com/gst/abstract.html?res=9C05E5DC1738E23BBC4052DFB566838F649EDEhttp://query.nytimes.com/gst/abstract.html?res=9E06EFDC1E3CE03ABC4952DFB7668383659EDE
http://query.nytimes.com/gst/abstract.html?res=9507E2D9153BEF34BC4153DFB566838E669FDE
http://www.nytimes.com/reuters/2014/08/22/business/22reuters-volume-loans.html
http://www.nytimes.com/reuters/2014/04/13/sports/cycling/13reuters-cycling-roubaix.html
http://www.nytimes.com/reuters/2014/02/18/business/18reuters-actavis-forestlabs.html
http://www.nytimes.com/2003/12/17/books/books-of-the-times-boon-for-pain-sufferers-and-thrill-seekers.html
http://www.nytimes.com/2002/05/26/realestate/commercial-property-westchester-builders-are-moving-to-fill-demand-for-lab-space.html
http://www.nytimes.com/reuters/2013/04/01/business/01reuters-india-novartis-patent.html
http://www.nytimes.com/2005/09/30/books/30book.html
http://www.nytimes.com/reuters/2014/07/11/business/11reuters-privateequity-pharmaceuticals-portfolio.htmlhttp://www.nytimes.com/aponline/2013/02/25/business/ap-us-business-highlights-.html
http://query.nytimes.com/gst/abstract.html?res=9806E1D61330E63ABC4052DFB3668388669EDE
http://www.nytimes.com/2013/12/19/opinion/the-rise-in-diagnoses-of-adhd.html
http://www.nytimes.com/reuters/2013/07/17/business/17reuters-gsk-china-compliance.html
http://www.nytimes.com/reuters/2014/02/18/business/18reuters-actavis-forestlabs.html
http://www.nytimes.com/2003/12/17/books/books-of-the-times-boon-for-pain-sufferers-and-thrill-seekers.html
http://www.nytimes.com/2002/05/26/realestate/commercial-property-westchester-builders-are-moving-to-fill-demand-for-lab-space.html
http://www.nytimes.com/reuters/2014/04/25/business/25reuters-investment-banking-activity-survey.html
http://dealbook.nytimes.com/2014/03/27/conscious-uncoupling-for-drug-makers/
http://www.nytimes.com/2011/12/18/magazine/reply-all-mitt-romney-bot.htmlhttp://www.nytimes.com/ref/health/healthguide/esn-eczema-trials.html
http://query.nytimes.com/gst/abstract.html?res=9E04E2DC1638E134BC4151DFB3668383679EDE
http://query.nytimes.com/gst/abstract.html?res=9900E5DF173FE53BBC4C52DFB066838C679EDE
http://www.nytimes.com/reuters/2014/03/25/business/25reuters-markets-stocks.html
http://www.nytimes.com/2012/07/10/sports/cycling/10iht-tour10.html
http://www.nytimes.com/2012/07/10/sports/cycling/10iht-tour10.html
http://query.nytimes.com/gst/fullpage.html?res=9A06E7D61331F934A15751C1A96E9C8B63
http://query.nytimes.com/gst/fullpage.html?res=9806EED9113FF932A25751C1A9619C8B63
http://www.nytimes.com/reuters/2013/08/30/sports/cycling/30reuters-cycling-spain.html
http://www.nytimes.com/reuters/2013/05/04/sports/cycling/04reuters-cycling-giro.htmlhttp://www.nytimes.com/reuters/2013/04/06/sports/cycling/06reuters-cycling-spain.html
http://www.nytimes.com/2011/05/16/business/16insider.html
http://dealbook.nytimes.com/2007/10/24/a-different-formula-for-a-biogen-deal/
http://query.nytimes.com/gst/abstract.html?res=990CE1DA1731EE34BC4F53DFBF66838B669EDE
http://query.nytimes.com/gst/abstract.html?res=9A04EED81239E33ABC4A52DFB066838F629EDE
http://www.nytimes.com/aponline/2012/08/16/business/ap-us-agilent-mover.html
http://www.nytimes.com/reuters/2012/06/28/sports/cycling/28reuters-cycling-tour-leipheimer.html
http://query.nytimes.com/gst/abstract.html?res=950DE4DB153BE53ABC4051DFB467838C679EDE
http://query.nytimes.com/gst/abstract.html?res=9A00E4DF153BE33BBC4D53DFB4668389659EDE
http://www.nytimes.com/2004/11/07/business/yourmoney/07advi.htmlhttp://www.nytimes.com/2004/01/30/business/media-business-advertising-study-fda-critic-argues-that-agency-slow-police.html
http://www.nytimes.com/reuters/2013/07/03/sports/cycling/03reuters-cycling-tour.html
http://www.nytimes.com/2001/03/15/nyregion/metro-briefing.html
http://www.nytimes.com/reuters/2014/07/05/sports/cycling/05reuters-cycling-tour-winner.html
http://www.nytimes.com/reuters/2014/07/05/sports/cycling/05reuters-cycling-tour-start.html
http://www.nytimes.com/reuters/2013/04/06/sports/cycling/06reuters-cycling-spain-winner.html
http://dealbook.nytimes.com/2009/06/15/pfizer-looks-to-raise-presence-in-emerging-markets/
http://www.nytimes.com/1999/04/13/nyregion/news-summary-international-sqn-917052.html
http://www.nytimes.com/1992/03/01/us/new-york-doctor-agrees-to-stop-injecting-silicone.html
http://query.nytimes.com/gst/abstract.html?res=9905E3DF1631E73BBC4A51DFB2668388679EDEhttp://6thfloor.blogs.nytimes.com/2014/05/26/behind-the-cover-story-michael-behar-on-star-trek-acupuncture-and-bioelectronics/
http://www.nytimes.com/1996/04/19/us/f-lee-bailey-strikes-deal-in-effort-to-get-out-of-jail.html
http://www.nytimes.com/reuters/2014/04/10/business/10reuters-markets-stocks.html
http://www.nytimes.com/2014/01/15/realestate/commercial/joel-s-marcus.html
http://www.nytimes.com/reuters/2013/07/03/sports/cycling/03reuters-cycling-tour-winner.html
http://www.nytimes.com/2012/07/03/sports/cycling/mark-cavendish-wins-tour-sprint-even-without-teammates-help.html
http://www.nytimes.com/reuters/2013/04/08/sports/cycling/08reuters-cycling-sky.html
http://tmagazine.blogs.nytimes.com/2008/01/28/davos-style-spittin-images/
http://www.nytimes.com/2006/05/05/business/05drug.html
http://www.nytimes.com/1995/03/08/business/business-technology-athena-shares-plunge-on-rejection-of-drug.htmlhttp://topics.nytimes.com/top/news/business/companies/iaso-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/horizon-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/aspenbio-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/china-pharma-holdings-inc/index.html
http://topics.nytimes.com/top/news/business/companies/kite-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/cardiome-pharma-corporation/index.html
http://topics.nytimes.com/top/news/business/companies/scolr-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/nutra-pharma-corporation/index.html
http://topics.nytimes.com/top/news/business/companies/recro-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/targeted-medical-pharma-inc/index.htmlhttp://dealbook.nytimes.com/2014/11/06/drug-maker-perrigo-to-acquire-omega-pharma/
http://topics.nytimes.com/top/news/business/companies/novadel-pharma-inc/index.html
http://topics.nytimes.com/top/news/business/companies/bio-blast-pharma-ltd/index.html
http://topics.nytimes.com/top/news/business/companies/zosano-pharma-corporation/index.html
http://www.nytimes.com/2014/11/11/opinion/big-pharma-and-ebola.html
http://www.nytimes.com/aponline/2014/11/06/business/ap-us-perrigo-omega-acquisition.html
http://www.nytimes.com/reuters/2014/10/20/business/20reuters-omega-actavis.html
http://www.nytimes.com/reuters/2014/10/29/technology/29reuters-google-pharmaceuticals-settlement.html
http://www.nytimes.com/reuters/2014/10/24/business/24reuters-hikma-pharma-warning-fda.html
http://www.nytimes.com/aponline/2014/10/03/business/ap-us-salix-inversion-scuttled.htmlhttp://www.nytimes.com/aponline/2014/09/22/business/ap-us-auxilium-pharmaceuticals-endo-international.html
http://www.nytimes.com/reuters/2014/10/09/business/09reuters-auxilium-pharm-offer-endo-intl.html
http://www.nytimes.com/reuters/2014/10/15/business/15reuters-markets-stocks-europe.html
http://www.nytimes.com/aponline/2014/09/16/business/ap-us-endo-auxilium.html
http://query.nytimes.com/gst/fullpage.html?res=9B01E0D71731F937A35755C0A9609C8B63
http://www.nytimes.com/reuters/2014/09/21/sports/cycling/21reuters-cycling-world-ttt.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320129.html
http://www.nytimes.com/reuters/2014/09/18/business/18reuters-sinclair-results.html
http://www.nytimes.com/2001/02/08/us/national-news-briefs-raids-in-kentucky-aim-at-deadly-new-drug.html
http://www.nytimes.com/2014/07/26/your-money/seeing-a-supersize-yacht-as-a-job-engine-not-a-self-indulgence.htmlhttp://www.nytimes.com/reuters/2014/09/23/business/23reuters-markets-stocks-ftse.html
http://www.nytimes.com/2007/07/21/business/21pharma.html
http://www.nytimes.com/2009/01/24/business/24pharma.html
http://www.nytimes.com/2005/08/27/business/27drug.html
http://www.nytimes.com/2001/08/07/nyregion/metro-briefing-connecticut-hartford-warning-on-painkiller.html
http://www.nytimes.com/2007/05/10/business/11drug-web.html
http://www.nytimes.com/2004/04/14/business/company-news-purdue-pharma-to-cut-nearly-300-jobs-in-connecticut.html
http://www.nytimes.com/2001/11/09/us/national-briefing-south-florida-inquiry-on-painkiller.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176796.html
http://www.nytimes.com/2004/11/06/business/06drug.htmlhttp://www.nytimes.com/2002/03/30/nyregion/c-corrections-311758.html
http://www.nytimes.com/reuters/2014/09/16/business/16reuters-auxilium-pharm-offer-endo-intl.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176788.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176800.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176770.html
http://www.nytimes.com/2010/12/16/business/16purdue.html
http://www.nytimes.com/2004/05/08/nyregion/city-claims-drug-maker-overcharged-for-painkiller.html
http://www.nytimes.com/reuters/2014/10/01/business/01reuters-flu-vaccine-analysis.html
http://www.nytimes.com/2003/08/12/business/generics-shake-up-a-drug-industry.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320145.htmlhttp://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320145.html
http://www.nytimes.com/2001/02/14/opinion/l-pain-relief-for-cancer-898465.html
http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html
http://www.nytimes.com/2001/08/09/us/national-briefing-science-and-health-new-form-for-abused-painkiller.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320110.html
http://www.nytimes.com/1994/11/22/business/biochem-pharma.html
http://www.nytimes.com/2012/07/07/health/oxycontins-effect-on-children-in-testing-by-purdue-pharma.html
http://www.nytimes.com/2003/09/04/business/media-business-advertising-maker-oxycontin-painkiller-that-addictive-sponsors.html
http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html
http://www.nytimes.com/2010/04/01/business/01sackler.htmlhttp://www.nytimes.com/2007/05/09/business/09purdue.html
http://www.nytimes.com/2001/08/18/opinion/l-abuse-of-oxycontin-756300.html
http://www.nytimes.com/2012/04/09/health/opioid-painkiller-prescriptions-pose-danger-without-oversight.html
http://www.nytimes.com/2010/04/01/business/01sackler.html
/data/daily/2007/10/05/526452.sgml
http://www.nytimes.com/2007/07/20/business/20oxy.html
http://www.nytimes.com/2005/06/08/business/08drug.html
http://www.nytimes.com/2004/04/18/nyregion/worth-noting-ruling-forces-company-to-cut-jobs-in-stamford.html
http://www.nytimes.com/2001/08/13/us/maker-chose-not-to-use-a-drug-abuse-safeguard.html
http://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176761.htmlhttp://www.nytimes.com/2000/11/19/magazine/l-pro-pharma-176753.html
http://topics.nytimes.com/top/news/business/companies/blackstone-lake-minerals-inc/index.html
http://topics.nytimes.com/top/news/business/companies/marshall-edwards-inc/index.html
http://topics.nytimes.com/top/news/business/companies/nexgen-biofuels-ltd/index.html
http://www.nytimes.com/2014/03/13/business/abuse-resistant-hydrocodone-could-sink-sales-of-new-drug.html
http://www.nytimes.com/2003/10/28/business/world-business-briefing-europe-germany-drug-maker-cuts-outlook.html
http://query.nytimes.com/gst/abstract.html?res=9806E5DA123CE23BBC4C52DFB7668382659EDE
http://www.nytimes.com/2007/06/19/business/19drug.html
http://www.nytimes.com/2004/01/06/business/judge-says-maker-of-oxycontin-misled-officials-to-win-patents.html
http://www.nytimes.com/2007/12/28/us/politics/28oxycontin.htmlhttp://www.nytimes.com/2000/01/20/business/world-business-briefing-europe-basf-pharma-reorganizes.html
http://www.nytimes.com/1996/08/20/business/profits-rise-12.8-at-schwarz-pharma.html
http://www.nytimes.com/1992/02/11/business/market-place-a-drug-flunks-a-stock-collapses.html
http://www.nytimes.com/2007/05/11/business/11drug.html
/data/daily/2004/09/30/138428.sgml
http://query.nytimes.com/gst/abstract.html?res=9400E7DF1238E23BBC4951DFBF66838F649EDE
http://query.nytimes.com/gst/fullpage.html?res=9505E7DB1531F93BA35755C0A9609C8B63
http://www.nytimes.com/2002/11/06/business/company-news-astrazeneca-to-appeal-us-court-ruling-on-generics.html
http://www.nytimes.com/1999/11/26/business/basf-says-it-may-sell-or-exchange-its-pharmaceuticals-unit.html
http://www.nytimes.com/1992/02/11/nyregion/mother-gets-prison-term-in-fatal-beating-of-boy.htmlhttp://www.nytimes.com/1999/11/26/business/basf-says-it-may-sell-or-exchange-its-pharmaceuticals-unit.html
http://www.nytimes.com/1992/02/11/nyregion/mother-gets-prison-term-in-fatal-beating-of-boy.html
http://www.nytimes.com/2003/11/05/business/company-said-to-develop-substitute-for-painkiller.html
http://www.nytimes.com/2002/05/30/nyregion/metro-briefing-connecticut-stamford-big-client-for-giuliani-s-company.html
http://www.nytimes.com/1999/06/19/business/company-news-alpharma-adds-german-generic-drug-business.html
http://www.nytimes.com/2008/09/01/business/worldbusiness/02drug.html
http://www.nytimes.com/2000/06/24/business/international-business-aventis-unit-sets-big-investment-biotechnology-start-up.html
http://www.nytimes.com/2007/07/31/business/31oxy.html
http://www.nytimes.com/2003/12/13/business/world-business-briefing-europe-germany-drug-maker-s-shares-surge.html
http://www.nytimes.com/2004/06/10/business/company-news-bradley-to-pay-183-million-for-unit-of-pharma-services.htmlhttp://www.nytimes.com/2007/07/31/business/31oxy.html
http://www.nytimes.com/2003/12/13/business/world-business-briefing-europe-germany-drug-maker-s-shares-surge.html
http://www.nytimes.com/2013/04/17/business/fda-bars-generic-oxycontin.html
http://www.nytimes.com/2002/12/12/business/technology-briefing-e-commerce-biovail-buys-2-companies-for-190-million.html
http://www.nytimes.com/2004/06/10/business/company-news-bradley-to-pay-183-million-for-unit-of-pharma-services.html
http://www.nytimes.com/2001/12/12/us/official-faults-drug-company-for-marketing-of-its-painkiller.html
http://dealbook.nytimes.com/2013/05/20/royalty-pharma-raises-bid-for-a-resistant-elan/
http://www.nytimes.com/2002/11/12/business/company-news-drug-tester-rejects-chairman-s-takeover-bid.html
http://www.nytimes.com/2001/06/12/us/national-briefing-mid-atlantic-west-virginia-state-sues-drug-maker.html
http://www.nytimes.com/2014/07/19/opinion/joe-nocera-cystic-fibrosis-drug-price.htmlhttp://www.nytimes.com/2004/01/13/business/oxycontin-manufacturer-seeks-delay-of-rival-drugs.html
http://www.nytimes.com/1999/07/16/business/company-news-canadian-drug-maker-offers-to-buy-scandipharm.html
http://www.nytimes.com/2004/01/07/business/connecticut-to-investigate-oxycontin-maker.html
http://www.nytimes.com/2002/04/25/business/company-news-vertex-says-arthritis-drug-falls-short-of-expectations.html
http://dealbook.nytimes.com/2010/06/03/astellas-extends-tender-offer-for-osi/
http://dealbook.nytimes.com/2013/06/17/battle-for-elan-in-doubt-after-shareholders-approve-buyback-plan/
http://www.nytimes.com/2013/04/20/opinion/the-loss-of-generic-oxycontin.html
http://www.nytimes.com/2002/10/15/business/company-news-head-of-drug-research-company-asks-to-buy-it.html
http://www.nytimes.com/2000/07/14/business/company-news-king-pharmaceuticals-agrees-to-buy-a-rival.html
http://www.nytimes.com/video/multimedia/100000002838976/big-pharma-braces-for-ma-wave.htmlhttp://query.nytimes.com/gst/fullpage.html?res=9C03E3D81631F934A25754C0A9619C8B63
http://www.nytimes.com/aponline/2014/02/11/business/ap-us-mallinckrodt-acquisition.html
http://www.nytimes.com/2001/07/26/us/effort-to-cut-a-painkiller-s-use.html
http://query.nytimes.com/gst/abstract.html?res=9902E2DF1630EE3ABC4851DFB366838B699FDE
http://www.nytimes.com/2014/07/24/business/fda-approves-pain-drug-meant-to-discourage-abuse.html
http://www.nytimes.com/2002/10/14/business/market-place-astrazeneca-has-won-battle-but-its-war-with-generic-drug-makers.html
http://www.nytimes.com/2001/10/28/us/overdoses-of-painkiller-are-linked-to-282-deaths.html
http://www.nytimes.com/2001/03/05/business/sales-of-painkiller-grew-rapidly-but-success-brought-a-high-cost.html
http://www.nytimes.com/1999/04/18/realestate/in-the-region-connecticut-drug-maker-buys-vacant-gte-building-in-stamford.html
http://www.nytimes.com/1984/01/14/business/monsanto-add-belgian-concern-st-louis-jan-13-ap-monsanto-company-announced-it.htmlhttp://www.nytimes.com/2006/11/24/business/24cancer.html
http://query.nytimes.com/gst/fullpage.html?res=9407E4D81E30F936A15751C1A9629C8B63
http://dealbook.nytimes.com/2010/05/16/osi-to-sell-itself-to-astellas-for-4-billion/
http://www.nytimes.com/1993/09/17/business/company-news-sandoz-in-pact-to-make-drugs-for-immune-system.html
http://www.nytimes.com/2007/12/11/business/worldbusiness/11drug.html
http://query.nytimes.com/gst/abstract.html?res=9504E5DE163FE731A25754C1A96F9C94619FD7CF
http://dealbook.nytimes.com/2013/06/14/elan-puts-itself-up-for-sale/
http://dealbook.nytimes.com/2013/06/06/elan-finds-creative-poison-pill-to-defend-against-a-hostile-bid/
http://www.nytimes.com/2010/05/17/business/global/17osi.html
http://www.nytimes.com/2003/05/28/business/company-news-drug-company-board-says-takeover-offer-is-too-low.htmlhttp://dealbook.nytimes.com/2013/02/25/buyout-offer-will-likely-not-end-elans-merger-ambitions/
http://www.nytimes.com/2013/01/16/nyregion/ny-police-to-track-drugstore-robbers-via-decoy-bottles.html
http://www.nytimes.com/2003/12/21/weekinreview/the-public-editor-you-can-stand-on-principle-and-still-stub-a-toe.html
http://www.nytimes.com/2001/01/03/business/world-business-briefing-americas-heart-drug-rights-acquired.html
http://dealbook.nytimes.com/2009/10/13/onyx-pharma-swallows-proteolix/
http://dealbook.nytimes.com/2007/01/02/british-healthcare-firm-sinclair-pharma-plans-ipo/
http://www.nytimes.com/1995/06/06/business/block-to-sell-parts-of-unit.html
http://dealbook.nytimes.com/2013/06/07/royalty-pharma-raises-its-bid-for-elan-again/
http://www.nytimes.com/2001/05/01/us/us-asks-painkiller-maker-to-help-curb-wide-abuse.html
http://www.nytimes.com/2001/03/09/opinion/l-the-trajectory-of-a-painkiller-320153.htmlhttp://www.nytimes.com/2004/08/27/business/company-news-merck-of-germany-to-buy-pfizer-generic-drug-unit.html
http://www.nytimes.com/2012/09/01/business/fda-approves-prostate-cancer-drug.html
http://www.nytimes.com/1994/11/24/business/company-news-biochem-drops-sale-of-north-american-vaccine-shares.html
http://www.nytimes.com/1992/10/07/business/continental-pharma-reports-earnings-for-year-to-july-31.html
http://www.nytimes.com/2014/01/29/health/drug-shows-promise-in-advanced-prostate-cancer-when-used-before-chemotherapy.html
http://www.nytimes.com/2003/07/26/business/company-news-mgi-pharma-wins-fda-approval-for-antinausea-drug.html
http://www.nytimes.com/reuters/2014/05/26/business/26reuters-china-pharmaceuticals-margins.html
http://www.nytimes.com/1992/10/01/business/biochem-pharma-reports-earnings-for-qtr-to-july-31.html
http://www.nytimes.com/aponline/2013/02/25/business/ap-us-royalty-pharma-elan.html
http://www.nytimes.com/aponline/2013/02/01/business/ap-us-kalobios-pharma-ipo.html